Alzheimer Bookmark and Share

ArticleDateSource
Revised rules aim to speed new Alzheimer's drugs--Pharmaceutical - Moreover
Quintiles makes equity investment in Kareus' Alzheimer's programme--Biotechnology - Moreover
Teva receives FDA approval to market Eisai's Alzheimer's treatment Aricept Tablets in the U.S.--Pharmaceutical - Moreover
Peering inside Alzheimer's brains--Nature Biotechnology
Alzheimer's genetic map--Nature Biotechnology
GOED Publishes Review on DHA Alzheimer's Study--PRWeb - Pharmaceuticals
CBDMT, The Market and Business Intelligence Company Reviews The Alzheimer's Disease Market --PRWeb - Biotechnology
Opinion: End of Alzheimer's starts todayMay 22, 2012CNN Top Stories
Red Meat and Butter "Could Raise Alzheimer's Risk," Harvard University Study May 21, 2012BioSpace
Alzheimer's Gene Causes Brain's Blood Vessels to Leak Toxins and Die, University of Rochester Study May 17, 2012BioSpace
Alzheimer's Gene Causes Brain's Blood Vessels to Leak Toxins and Die May 17, 2012BioSpace - Featured Stories
Roche's Genentech to Take Part in First-ever Alzheimer's Prevention Trial May 16, 2012BioSpace
NIH taps Genentech drug for pioneering Alzheimer's study May 16, 2012FiercePharma
Scientists Hunt Ways to Stall Alzheimer's Earlier May 16, 2012BioSpace - Featured Stories
Rep. Fattah Commends the Administration for "all-out assault" on Alzheimer's and other brain diseasesMay 15, 2012Biotech News - PR Newswire
Rep. Fattah Commends the Administration for "all-out assault" on Alzheimer's and other brain diseasesMay 15, 2012Pharma News - PharmiWeb
Genentech drug picked for pioneering $100M Alzheimer's trialMay 15, 2012FierceBiotech
Groundbreaking Alzheimer's Disease Prevention Trial AnnouncedMay 15, 2012Pharma News - PR Newswire
Roche Alzheimer's drug picked for major testMay 15, 2012Health News - CNBC
Alzheimer's Association Applauds The Creation Of The First National Alzheimer's PlanMay 15, 2012Medical Pharma - PR Newswire
U.S. launches ambitious Alzheimer's plan with research pushMay 15, 2012Health News - CNBC
Opko Health, Inc. Catches Investors' Attention With Alzheimer's Test May 14, 2012BioSpace
Roche Bets on an Alzheimer's Drug May 14, 2012BioSpace
NIH pumps $6M into DNA analysis for Alzheimer's planMay 14, 2012FierceBiotech IT
Alzheimer's research fraud case set for trialMay 11, 2012Health News - CNBC
Prana Chief Scientific Advisor to Give Plenary Lecture at Alzheimer's Symposium in Stockholm Featuring New Targets and DrugsMay 09, 2012Marketwire - Pharma and Biotech
mAb Therapeutics for Alzheimer Disease Unlikely to Be Fully Successful, According to GEN PollMay 08, 2012Inside Industry - Gen
Intellect Neurosciences Adds Two New Tau Programs to its Alzheimer's Disease Development PipelineMay 07, 2012Biotech News - PR Newswire
Nanobody for Alzheimer's Disease From The Alliance With Boehringer Ingelheim Moves Closer Towards Phase I Clinical TrialsApril 25, 2012Marketwire - Pharma and Biotech
Oligomerix Raises $2M for Tau Protease Inhibitor Alzheimer Disease ProgramApril 23, 2012Inside Industry - Gen
Alzheimer's Association to Honor Legendary University of Tennessee Lady Vols Head Coach Emeritus Pat Summitt and Son Tyler at National Alzheimer's DinnerApril 23, 2012Medical Pharma - PR Newswire
Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimer's Research Group at University of California Irvine to Test First in Class Dual Target VaccineApril 17, 2012Biotech News - PR Newswire
Piramal lays claim to a late-stage imaging rival for Lilly's Alzheimer's agentApril 16, 2012FierceBiotech
Los Angeles Syndicate of Technology Announces that Portfolio Company, Sanguine BioSciences, has Received Approval to Serve Patients Diagnosed with Multiple Sclerosis, Alzheimer's Disease, and Parkinson's DiseaseApril 16, 2012Pharma News - PR Newswire
New Method May Help Detect Marker for Alzheimer's Disease EarlierApril 15, 2012Clinical Trials - PR Newswire
The Alzheimer's Drug Discovery Foundation and Charles River Announce Awards for the Cognitive Aging and Alzheimer's Disease Research ProgramApril 10, 2012Clinical Trials - PR Newswire
Siemens Announces First Integrated Amyloid Imaging Solution in the U.S. Market for Use in Evaluation of Alzheimer's Disease and Other Causes of Cognitive DeclineApril 10, 2012Biotech News - PR Newswire
Johnson & Johnson Alzheimer's Med Cut Chemical Tied to Brain Tangles April 03, 2012BioSpace
Research and Markets: 2012 Epidemiology Report: Alzheimer's Disease - Differential Aging between Genders will Dramatically Impact Prevalent CasesMarch 29, 2012Pharma News - Business Wire
<b><i>PLoS ONE</i></b> Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing PRANA Biotechnology's PBT2 March 26, 2012BioSpace - Breaking News
DiaGenic and GE Healthcare to Develop Blood-Based Test for Mild Cognitive Impairment, a Disorder Associated with Risk for Alzheimer's DiseaseMarch 26, 2012Biotech News - Business Wire
PLoS ONE Journal Publishes Mechanistic Model of Alzheimer's Disease Endorsing Prana's PBT2March 26, 2012Marketwire - Pharma and Biotech
FDA Approves Eisai Company, Ltd.'s Higher Aricept Dose for Alzheimer's Despite Warning March 23, 2012BioSpace
Alzheimer's Association Awards Largest Ever Research Grant To The Dominantly Inherited Alzheimer's Network (DIAN) For Innovative Therapy TrialsMarch 20, 2012Clinical Trials - PR Newswire
Latest anti-RAGE compound defeats Alzheimer's symptoms in miceMarch 16, 2012FierceBiotech Research
New Clues For the Cause of Alzheimer's DiseaseMarch 16, 2012Medical Pharma - PR Newswire
Grifols Nabs 51% Stake in Alzheimer Disease Dx, Vaccines Firm AraclonMarch 16, 2012Inside Industry - Gen
Grifols Nabs 51% Stake in Alzheimer Disease Dx and Vaccines Firm AraclonMarch 16, 2012Inside Industry - Gen
New Alzheimer's Marker Strongly Predicts Mental Decline, Washington University in St. Louis Study March 08, 2012BioSpace
Evidence-Based Medicine Debate Series Addresses Controversial Topics in the Diagnosis and Management of Alzheimer's DiseaseMarch 08, 2012Biotech News - PR Newswire
Aricept helps moderate to severe Alzheimer's tooMarch 07, 2012Health News - CNBC
Symptoms of late-stage Alzheimer's can be delayedMarch 07, 2012New Scientist - Health
PRANA Biotechnology Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial March 07, 2012BioSpace - Breaking News
Vitamin D May Help Treat Alzheimer's Disease, University of California, Los Angeles (UCLA) Study March 07, 2012BioSpace
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease TrialMarch 07, 2012Marketwire - Pharma and Biotech
Intellect Neurosciences a reçu un Avis d'autorisation du Bureau des Brevets et des marques commerciales des États-Unis pour sa plateforme de technologies d'immunothérapie pour la maladie d'Alzheimer ANTISENILIN®March 07, 2012Biotech News - PR Newswire
Intellect Neurosciences erhält für seine Immuntherapie-Technologieplattform ANTISENILIN® zur Behandlung von Alzheimer die Patentankündigung des US-Patent- und MarkenamtsMarch 06, 2012Biotech News - PR Newswire
Elan chief to stick around until Alzheimer's data breaksMarch 01, 2012FiercePharma
Blockade of Learning and Memory Genes May Occur Early in Alzheimer's Disease: Treatable in Mice, Massachusetts Institute of Technology (MIT) Study March 01, 2012BioSpace
Elan Corporation PLC Extends Stay as Phase 3 Alzheimer Data Looms March 01, 2012BioSpace
Simon Fraser University Researchers Test Sugary Solution to Alzheimer's Disease February 29, 2012BioSpace
Satori Secures $15M to Further Preclinical Alzheimer DrugsFebruary 23, 2012Inside Industry - Gen
Satori snags $15M to fuel a trial on Alzheimer's drugFebruary 23, 2012FierceBiotech
Several Drugmakers Pursue BioTie Therapies Corp. for Alzheimer's Drug February 21, 2012BioSpace - Breaking News
Global Alzheimer's researchers seek cloud-based infrastructure to share dataFebruary 21, 2012FierceBiotech IT
AARP Idaho Commends Senate Passage of Plan to Tackle State's Alzheimer's IssuesFebruary 20, 2012Medical Pharma - PR Newswire
Flu, over time, could increase Alzheimer's vulnerability February 17, 2012FierceBiotech Research
Turmeric-Based Drug Effective on Alzheimer Flies, Link??ping University Study February 15, 2012BioSpace
Pfizer R&D chief talks up chances for late-stage Alzheimer's drugFebruary 14, 2012FierceBiotech
Preclinical study triggers 'massive response' from desperate Alzheimer's patientsFebruary 13, 2012FierceBiotech
PHARNEXT Raises an Additional ???8 Million for Its PleotherapyTM Platform Applied to the Treatment of Charcot-Marie Tooth Disease and Alzheimer's Disease February 09, 2012BioSpace
PHARNEXT Raises an Additional €8 Million for Its PleotherapyTM Platform Applied to the Treatment of Charcot-Marie Tooth Disease and Alzheimer's DiseaseFebruary 09, 2012Pharma News - Business Wire
Research Appropriator Applauds New Funds to Attack Alzheimer's DiseaseFebruary 07, 2012Medical Pharma - PR Newswire
Collaborations Between Public and Private Sector Are Critical to Advance Alzheimer's ResearchFebruary 07, 2012Medical Pharma - PR Newswire
Obama to boost Alzheimer's fundingFebruary 07, 2012CNN Top Stories
Alzheimer's Foundation of America Applauds Administration Efforts to Boost Federal Budget for Alzheimer's Disease Research and Caregiver SupportFebruary 07, 2012Medical Pharma - PR Newswire
NCCDP Offers Free Staff In-Services for Alzheimer's and Dementia Staff Education Week, Feb. 14th- 21stFebruary 07, 2012Medical Pharma - PR Newswire
Alzheimer's Association Commends the Obama Administration for Dedication of New Resources to Alzheimer'sFebruary 07, 2012Medical Pharma - PR Newswire
Intellect Neurosciences Files New Patent Applications for Immunotherapy Methods to Target Abnormal Tau Protein in Treatment of Alzheimer's diseaseFebruary 07, 2012Biotech News - PR Newswire
Is Lilly betting the farm on its high-stakes Alzheimer's gamble?February 02, 2012FierceBiotech
Prana Comments on Nature Medicine, PNAS and Journal of Alzheimer's Disease Articles That Highlight the Role of Metals in Neurological DiseasesFebruary 02, 2012Marketwire - Pharma and Biotech
Lilly Alzheimer's drug an unlikely ace in the holeFebruary 01, 2012Health News - CNBC
Study gives new clues on how Alzheimer's spreadsFebruary 01, 2012Health News - CNBC
Lilly's losses put pressure on key Alzheimer's program January 31, 2012FierceBiotech
Scientists build human Alzheimer's neurons in labJanuary 26, 2012FierceBiotech Research
Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's CareJanuary 26, 2012Pharma News - PR Newswire
Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer’s CareJanuary 26, 2012Pharma News - Business Wire
MassBay scientists help discover Alzheimer's indicatorJanuary 26, 2012Biotechnology - Moreover
Keeping Brain Sharp May Ward Off Alzheimer's Protein, University of California, Berkeley (CAL) Study January 24, 2012BioSpace
Aphios Pockets $2.4M SBIR Grant for Preclinical Alzheimer Disease CandidateJanuary 24, 2012Inside Industry - Gen
Keeping brain sharp may ward off Alzheimer's proteinJanuary 23, 2012Science News - Reuters
Data on Navidea Biopharmaceuticals???s AZD4694 Presented by the Banner Alzheimer's Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI) January 20, 2012BioSpace - Breaking News
University of Calgary Study Identifies a New Way Brain Cells Die in Alzheimer's Disease January 20, 2012BioSpace
Obama seeks to beat Alzheimer's by 2025January 19, 2012FierceBiotech Research
Research and Markets: Alzheimer's Disease Product Profiles: immunotherapies can revolutionize treatment paradigmJanuary 19, 2012Pharma News - Business Wire
Analysis: Goal for Alzheimer's drug by 2025 too ambitious?January 19, 2012Health News - CNBC
Sequel to Emmy Award-Winning Documentary on Early-Onset Alzheimer's Premieres January 20 on RLTVJanuary 19, 2012Medical Pharma - PR Newswire
Active Compounds Against Alzheimer's Disease: New Insights Thanks to Simulations, University of Zurich Study January 17, 2012BioSpace
Pfizer Inc. Ditches $725 Million Medivation, Inc. Pact as Phase 3 Alzheimer Trial Disappoints January 17, 2012BioSpace
Medivation and Pfizer Announce Results From Phase 3 Concert Trial of Dimebon in Alzheimer's DiseaseJanuary 17, 2012Marketwire - Pharma and Biotech
Alzheimer's Med Seems Ineffective in Those With Down Syndrome, King's College London Study January 11, 2012BioSpace
Targacept: Alzheimer's drug studies will continueJanuary 05, 2012Health News - CNBC
Targacept buoyed by AZ's commitment to Alzheimer's programJanuary 05, 2012FierceBiotech
Targacept, Inc. Sees More AstraZeneca PLC Backing on Alzheimer's Drug January 05, 2012BioSpace
Biotechs round up new venture cash for COPD, Alzheimer's programsJanuary 04, 2012FierceBiotech
Probiodrug Secures €15M to Progress Glutaminyl Cyclase Inhibitor Alzheimer DrugJanuary 04, 2012Inside Industry - Gen
Use Biomarkers in Alzheimer's Disease Clinical Trials, Says Expert GroupJanuary 04, 2012Biotech News - PR Newswire
Probiodrug Secures €15M to Progress Glutaminyl Cyclase Inhibitor Alzheimer DrugJanuary 04, 2012Inside Industry - Gen
Delay in seeking diagnosis for dementia symptoms results in huge treatment gap for Canadians according to new Alzheimer Society surveyJanuary 04, 2012Clinical Trials - PR Newswire
Tufts University Study Finds Another Potential Risk Factor for Developing Dementia and Alzheimer's Disease in Women January 03, 2012BioSpace
Combination of biomarkers indicates high risk of Alzheimer's in futureJanuary 03, 2012Pharmaceutical - Moreover
Alzheimer Disease - New Drugs, Markets and CompaniesJanuary 03, 2012Pharma News - PR Newswire
Alzheimer's Association® Successfully Advocates on Behalf of Constituents to Secure Funding for Alzheimer's Research and ProgramsDecember 23, 2011Medical Pharma - PR Newswire
Gladstone, Bristol Myers Squibb strike Alzheimer's research dealDecember 23, 2011Health News - BizJournals.com
Proteome confirms progress on Alzheimer's targetDecember 22, 2011Pharmaceutical - Moreover
Merck Sharp & Dohme Axes Alzheimer Deal with Acumen Pharmaceuticals Inc. December 21, 2011BioSpace
Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimer's Disease From MerckDecember 21, 2011Biotech News - PR Newswire
Acumen recupera los derechos mundiales para los productos terapéuticos y de diagnóstico para el Alzheimer de MerckDecember 21, 2011Biotech News - PR Newswire
Acumen Pharmaceuticals récupère les droits mondiaux des traitements et diagnostics à base d’anticorps anti ADDL dans le traitement de la maladie d’Alzheimer détenus auparavant par MerckDecember 21, 2011Biotech News - PR Newswire
Discovery could lead to memory pill for Alzheimer's patientsDecember 20, 2011FierceBiotech Research
Managing Holiday Stress with Alzheimer's Disease - Tips for CaregiversDecember 15, 2011Pharma News - PharmiWeb
PRANA Biotechnology (PRAN) Commences Alzheimer's Trial RecruitmentDecember 15, 2011Biotechnology - Moreover
PRANA Biotechnology Commences Alzheimer's Trial Recruitment December 15, 2011BioSpace - Breaking News
Alzheimer's Drug Candidate May Be First to Prevent Disease Progression, Mouse Study Suggests, Salk Institute for Biological Studies Reveals December 15, 2011BioSpace
Antioxidant Has Potential in the Alzheimer's Fight, University of Georgia Study December 15, 2011BioSpace
Prana Commences Alzheimer's Trial RecruitmentDecember 15, 2011Marketwire - Pharma and Biotech
Merck & Co., Inc. Chemists Use High-Tech Science to Combat Alzheimer's Disease Challenge December 14, 2011BioSpace
Eisai Company, Ltd. Submits Application in Japan for New Dry Syrup Formulation of its Alzheimer's Disease Treatment Aricept December 13, 2011BioSpace - Breaking News
Australian scientists produce promising results on Alzheimer's vaccine developmentDecember 13, 2011Pharmaceutical - Moreover
<b>Banner Sun Health Research Institute</b> Shows Statins May be Beneficial in Treating Alzheimer's Disease December 12, 2011BioSpace - Featured Stories
Rensselaer Polytechnic Institute Researchers Design Alzheimer's Antibodies December 12, 2011BioSpace - Featured Stories
Australian scientists find new Alzheimer's vaccineDecember 10, 2011Pharmaceutical - Moreover
Research Shows Statins May be Beneficial in Treating Alzheimer's DiseaseDecember 09, 2011Pharma News - PharmiWeb
Eli Lilly and Company Shares Rise on Optimism for Alzheimer's Drug December 07, 2011BioSpace
Surge in Lilly shares highlights perils, potential of Alzheimer's drugsDecember 07, 2011FierceBiotech
Prana gets OK for Alzheimer's trialDecember 06, 2011Biotechnology - Moreover
Bupa Health Foundation and Alzheimer's Australia Announce UK Availability of Brain Health AppDecember 06, 2011Medical Pharma - PR Newswire
Eating Fish Reduces Risk of Alzheimer's DiseaseNovember 30, 2011Medical Pharma - PR Newswire
Alzheimer's damage reversed by deep brain stimulationNovember 23, 2011New Scientist - Health
Prana earns approval to begin Alzheimer's drug trialNovember 23, 2011Biotechnology - Moreover
PRANA Biotechnology (PRAN) Receives Approval for Alzheimer's TrialNovember 22, 2011Biotechnology - Moreover
Prana has OK for Alzheimer's study; shares riseNovember 22, 2011Biotechnology - Moreover
PRANA Biotechnology Receives Approval for Alzheimer's Trial November 22, 2011BioSpace - Breaking News
Prana Receives Approval for Alzheimer's TrialNovember 22, 2011Marketwire - Pharma and Biotech
Prana Biotechnology to start 12 month trial of Alzheimer's treatmentNovember 22, 2011Biotechnology - Moreover
AgingCare.com Launches the Caregiver's Guide to Alzheimer's DiseaseNovember 17, 2011Pharma News - PharmiWeb
A New Mechanism for Tau Protein Pathology in Alzheimer's Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual MeetingNovember 16, 2011Biotech News - PR Newswire
The New York Academy of Sciences and One Mind for Research Unveil Partnership to Accelerate Translational Science in Alzheimer's Disease and DementiaNovember 16, 2011Clinical Trials - PR Newswire
Research and Markets: Alzheimer's Disease Global Clinical Trials Review, H2, 2011November 16, 2011Clinical Trials - Business Wire
Webinar: Detecting Pro-Cognitive Effects in Clinical Drug Trials: Case Studies from Alzheimer's DiseaseNovember 15, 2011Biotechnology - Moreover
Probiodrug AG Announces Top-Line Results of the First Clinical Study of PQ912 for Treatment of Alzheimer's Disease November 14, 2011BioSpace
Prana Biotechnology's PBT2 shows potential to reverse effects of Alzheimer's ...November 14, 2011Biotechnology - Moreover
Probiodrug Announces Top-Line Results of the First Clinical Study of PQ912 for Treatment of Alzheimer's DiseaseNovember 14, 2011Biotech News - PR Newswire
Probiodrug and Its Collaborators Will Present Novel Insights into the Pathophysiology of Alzheimer's Disease at Society for Neuroscience's Neuroscience 2011 Conference in Washington, D.C.November 09, 2011Biotech News - PR Newswire
Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimer's Immunotherapy ProgramsNovember 08, 2011Biotech News - PR Newswire
Alzheimer's Foundation of America to Host 9th Annual National Memory Screening DayNovember 07, 2011Medical Pharma - PR Newswire
Alzheimer's center launched at UBNovember 04, 2011Health News - BizJournals.com
Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent ApplicationNovember 03, 2011Pharma News - PR Newswire
Yeast Model Connects Alzheimer's Disease Risk and Amyloid Beta Toxicity, Whitehead Institute Study October 31, 2011BioSpace
Prana Biotechnology Shares Soar on Alzheimer's Drug NewsOctober 26, 2011Biotechnology - Moreover
Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimer's Disease and Other ProteinopathiesOctober 26, 2011Biotech News - PR Newswire
Neuronetrix Helps Put ERP Biomarkers in the Spotlight at Alzheimer's Clinical Trial ConferenceOctober 25, 2011Marketwire - Pharma and Biotech
Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies (BIZ)October 24, 2011Pharmaceutical - Moreover
theVisualMD Delivers a Never Before Seen View of Alzheimer's DiseaseOctober 24, 2011Medical Pharma - PR Newswire
Accera, Inc. Donates $50,000 to the Alzheimer's Foundation of America for National Memory Screening DayOctober 24, 2011Biotech News - PR Newswire
Antiviral Drugs May Slow Alzheimer's Progression, University of Manchester Study October 20, 2011BioSpace
<b>Functional Neuromodulation Inc.</b> Closes $10.4 Million Financing Agreements to Fund Phase II Testing for Potential Alzheimer's Treatment October 17, 2011BioSpace
Genetic Profile Identified for Alzheimer's Patients Showing Heightened Response to Accera's Breakthrough Product Axona®October 17, 2011Pharma News - PR Newswire
Findings from DiaGenic ASA, Pfizer Inc. R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer Disease October 14, 2011BioSpace
Findings from DiaGenic, Pfizer R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer DiseaseOctober 14, 2011Biotech News - Business Wire
DiaGenic ASA: Findings from DiaGenic, Pfizer R&D Collaboration Show Promising Early Results for Blood-based Test for Early Alzheimer DiseaseOctober 14, 2011Biotech News - Business Wire
Care to Cure Alzheimer's Conference to Help NH FamiliesOctober 12, 2011Medical Pharma - PR Newswire
Roche's Experimental Alzheimer's Drug Gantenerumab Looks Promising in Phase I October 11, 2011BioSpace
New Alzheimer's drug trial launching October 11, 2011Health News - BizJournals.com
Roche spotlights PhI efficacy of Alzheimer's antibody October 11, 2011FierceBiotech
Roches announces postive data for Alzheimer's drugOctober 11, 2011Pharmaceutical - Moreover
Study Shows That Roche's Investigational Drug for Alzheimer's Disease Removes Amyloid Plaques From the BrainOctober 10, 2011Biotech News - PR Newswire
<b>Exonhit</b> Enters Into Research Agreement With Pfizer Inc. to Identify Alzheimer's Disease Biomarkers October 10, 2011BioSpace - Breaking News
Targacept, Inc. Initiates a Phase 2b Study of AZD3480 in Alzheimer's Disease October 10, 2011BioSpace - Breaking News
Servier Exercises Option to Cortex’s AMPAKINE® CX1632, An Innovative Compound in Clinical Development for Alzheimer's DiseaseOctober 06, 2011Pharma News - Business Wire
Star Scientific annonce la publication d'un premier article évalué par des pairs sur l'anatabine et la maladie d'Alzheimer par l'Institut RoskampOctober 05, 2011Clinical Trials - PR Newswire
Fruit flies may help find Alzheimer's cureOctober 05, 2011Health News - BizJournals.com
Star Scientific Reports First Peer-Reviewed Article on Anatabine and Alzheimer's Disease by Roskamp InstituteOctober 04, 2011Clinical Trials - PR Newswire
WNBA All-Star Kara Lawson Announces Major Effort to Fight Alzheimer's in Honor of Pat Summitt, Tennessee Women's Basketball CoachOctober 03, 2011Pharma News - PharmiWeb
Alzheimer's Therapeutics Reviewed by NeuroPerspectiveOctober 03, 2011Marketwire - Pharma and Biotech
Study Suggests Link Between Sleep Deprivation, Alzheimer's Risk, Washington University Study September 29, 2011BioSpace
Prospective Alzheimer's vax homes in on amyloid deliverySeptember 28, 2011FierceVaccines
Transition Therapeutics Inc. Announces Publication of ELND005 Phase 2 Clinical Study Data in Alzheimer's Disease September 27, 2011BioSpace - Breaking News
University of Kentucky spinoff licensed to develop Alzheimer's treatmentSeptember 22, 2011Pharmaceutical - Moreover
Industry supports Alzheimer's DaySeptember 21, 2011Pharmaceutical - Moreover
Nasdaq Lead Stock; Prana Biotechnology jumps after Update on Alzheimer TreatmentSeptember 20, 2011Biotechnology - Moreover
Prana's PBT2 can restore cognition in Alzheimer's DiseaseSeptember 20, 2011Biotechnology - Moreover
Diabetes doubles Alzheimer's riskSeptember 19, 2011CNN Top Stories
Prana Biotechnology ([[PRAN +16%) soars after The Journal Of Neurochemistry publishes an update on Prana's experimental drug PBT2 for the treatment of Alzheimer's Disease. The study explains how the drug is able to restore cognition in Alzheimer's suffSeptember 19, 2011Biotechnology - Moreover
Alzheimer's Foundation of America Responds to Broadcaster Pat Robertson's Comments About Brain DisorderSeptember 15, 2011Medical Pharma - PR Newswire
Alzheimer's Foundation of America Memory Screening Day Garners Widespread Support of Leading Professional GroupsSeptember 15, 2011Medical Pharma - PR Newswire
Anavex to present data on ANAVEX 2-73, lead compound for Alzheimer's disease, at Japan Neuroscience Society special symposiumSeptember 15, 2011Biotech News - PR Newswire
Alzheimer's Rising Tide of New Cases Floods CaregiversSeptember 14, 2011Pharma News - PharmiWeb
High Cholesterol Might Be Linked to Alzheimer's Disease, Study September 13, 2011BioSpace
El World Alzheimer Report 2011 muestra los beneficios de la diagnosis primaria del AlzheimerSeptember 13, 2011Medical Pharma - PR Newswire
Le Rapport mondial de 2011 sur la maladie d'Alzheimer montre que le diagnostic précoce offre des avantages financiers, sociaux et de santéSeptember 13, 2011Medical Pharma - PR Newswire
Der Welt-Alzheimer-Bericht 2011 zeigt die gesundheitlichen, finanziellen und sozialen Vorteile der frühzeitigen Diagnose von Alzheimer aufSeptember 13, 2011Medical Pharma - PR Newswire
World Alzheimer Report 2011 Shows Early Diagnosis of Alzheimer's Disease Has Health, Financial and Social BenefitsSeptember 13, 2011Medical Pharma - PR Newswire
Relatório Mundial de Alzheimer de 2011 mostra que o diagnóstico antecipado do Mal de Alzheimer apresenta benefícios de saúde, financeiro e socialSeptember 13, 2011Medical Pharma - PR Newswire
Informe Mundial Alzheimer 2011 muestra que el diagnóstico temprano del Mal de Alzheimer tiene beneficios de salud, financieros y socialesSeptember 13, 2011Medical Pharma - PR Newswire
Insulin spray aided memory in Alzheimer's studySeptember 12, 2011Health News - CNBC
Evotec shares surge on $830M Alzheimer's pact with RocheSeptember 06, 2011FierceBiotech
Roche, Evotec AG Sign Alzheimer's Pact Worth Up to $830 Million September 06, 2011BioSpace
Alzheimer's clue homes in on musical memoryAugust 31, 2011New Scientist - Health
Alzheimer's trial database finds takers in W. FloridaAugust 28, 2011FierceBiotech IT
KU Med Center earns grant, national Alzheimer's designationAugust 16, 2011Health News - BizJournals.com
Jackson Lab off the hook in Alzheimer's mice lawsuitAugust 15, 2011FierceBiotech Research
Global Standardization for Alzheimer's Biomarkers Moves a Major Step Closer to RealityAugust 11, 2011Pharma News - PR Newswire
Foundation Venture Capital Group Investment Shows Promise in Diagnosis of Alzheimer's Disease Using a Drop of BloodAugust 03, 2011Medical Pharma - PR Newswire
Anavex presents data on neuroprotective evidence for ANAVEX 2-73, lead compound for Alzheimer's diseaseJuly 26, 2011Biotech News - PR Newswire
Intellect Neurosciences, Inc. Obtains Notice of Allowance for Alzheimer's Beta Amyloid Vaccine from the Japan Patent Office in Relation to the Company's RECALL-VAX(TM) TechnologyJuly 21, 2011Pharmaceutical - Moreover
PRANA Biotechnology (PRAN) Release: PBT2's 'Mechanism of Action' Presented in a Plenary Lecture at International Conference on Alzheimer's Disease (ICAD) on July 21 in ParisJuly 21, 2011Biotechnology - Moreover
UPDATED: Lilly's failed Alzheimer's drug raises troubling questions for drug classJuly 21, 2011FierceBiotech
PRANA Biotechnology (PRAN) Release: PBT2's 'Mechanism of Action' Presented in a Plenary Lecture at International Conference on Alzheimer's Disease (ICAD) on JulyJuly 21, 2011Biotechnology - Moreover
Lilly's failed Alzheimer's drug raises troubling questions for drug classJuly 21, 2011FierceBiotech
PBT2's 'Mechanism of Action' Presented in a Plenary Lecture at International Conference on Alzheimer's Disease (ICAD) on July 21 in ParisJuly 21, 2011Marketwire - Pharma and Biotech
International Poll Shows Many Fear Alzheimer's as Much as CancerJuly 20, 2011Pharmaceutical - Moreover
Bilan des progrès de la recherche depuis la Conférence internationale 2011 de l'Alzheimer's AssociationJuly 20, 2011Medical Pharma - PR Newswire
Fortschrittliche Forschungsarbeiten auf der Alzheimer's Association International Conference 2011 vorgestelltJuly 20, 2011Medical Pharma - PR Newswire
New studies raise hopes for Pfizer, J&J Alzheimer's treatmentJuly 20, 2011FierceBiotech
Une nouvelle etude montre un ralentissement du taux de l'atrophie hippocampique chez des patients atteints de la maladie d'Alzheimer et traités par Aricept(R) (donépézil)July 20, 2011Biotech News - PR Newswire
Alzheimer's Drug from Pfizer Inc., Johnson & Johnson May Prove Safer July 20, 2011BioSpace
Alzheimer's Association begrüßt Präsident Nicolas Sarkozy auf internationaler KonferenzJuly 20, 2011Medical Pharma - PR Newswire
Le président Nicolas Sarkozy interviendra lors de la conférence internationale organisée par l'Alzheimer's AssociationJuly 20, 2011Medical Pharma - PR Newswire
Alzheimer's Association Welcomes President Nicolas Sarkozy to International ConferenceJuly 20, 2011Medical Pharma - PR Newswire
La Alzheimer's Association da la bienvenida a la conferencia internacional al presidente Nicolas SarkozyJuly 20, 2011Medical Pharma - PR Newswire
Special report: With Alzheimer's in the genes, when do you test?July 20, 2011Health News - CNBC
Research Advances from the Alzheimer's Association International Conference 2011July 20, 2011Medical Pharma - PR Newswire
Se presentan los avances en investigación en la Alzheimer's Association International Conference 2011July 20, 2011Medical Pharma - PR Newswire
International Study of Genetic Alzheimer's Disease Gives Clues to Presymptomatic Detection and Progression of the DiseaseJuly 20, 2011Clinical Trials - PR Newswire
Jellyfish Protein a Hot Topic at International Conference on Alzheimer's DiseaseJuly 20, 2011Biotechnology - Moreover
Late Breaking Research Results From the Alzheimer's Association International Conference 2011July 20, 2011Medical Pharma - PR Newswire
International Survey Reveals Attitudes Towards Alzheimer's Diagnosis and TreatmentJuly 20, 2011Medical Pharma - PR Newswire
Los españoles preferirían saber si padecen Alzheimer antes incluso de presentar síntomas, según un estudio internacionalJuly 20, 2011Biotech News - PR Newswire
È stato presentato il 4o Alzheimer's Awards per la ricerca di migliori soluzioni globali nella cura della demenza senileJuly 19, 2011Medical Pharma - PR Newswire
Annonce des 4èmes Prix Alzheimer - A la recherche de solutions mondiales pour de meilleurs soins de la démenceJuly 19, 2011Medical Pharma - PR Newswire
Se anuncian los cuartos Alzheimer AwardsJuly 19, 2011Medical Pharma - PR Newswire
Hoag's Orange County Vital Aging Program Data Presented at the International Conference on Alzheimer's DiseaseJuly 19, 2011Medical Pharma - PR Newswire
4th Alzheimer's Awards Announced in Search of Global Solutions for Better Dementia CareJuly 19, 2011Pharma News - PharmiWeb
Eli Lilly and Company Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease Research July 19, 2011BioSpace - Breaking News
Eli Lilly and Company Says Alzheimer Patients Didn't Improve July 19, 2011BioSpace
Brain Swelling May Be Common With Alzheimer's Drugs Harvard Medical School Study July 19, 2011BioSpace
New Studies Underscore Global Importance of Mild Cognitive Impairment in Alzheimer's Disease ContinuumJuly 19, 2011Medical Pharma - PR Newswire
Lilly Presents Follow-Up Data on Semagacestat to Assist Future Alzheimer's Disease ResearchJuly 19, 2011Pharma News - PR Newswire
New Global Model of Alzheimer's Risk Suggests a 25 Percent Reduction in Presumed Risk Factors Could Lower Alzheimer's Cases by 3 Million WorldwideJuly 19, 2011Clinical Trials - PR Newswire
Exclusive: GE to soon seek FDA OK for Alzheimer's imaging agentJuly 18, 2011Health News - CNBC
Orasi Medical Announces Clinical Results Measuring Alzheimer's Disease SeverityJuly 18, 2011Marketwire - Pharma and Biotech
Brain swelling may be common with Alzheimer's drugsJuly 18, 2011Health News - CNBC
Falls Could Signal Early Alzheimer's Disease, Washington University Study July 18, 2011BioSpace - Featured Stories
Florbetapir "Imaging to Autopsy" Study Awarded Alzheimer's Association's 2011 de Leon Prize in NeuroimagingJuly 18, 2011Pharma News - PR Newswire
Women at the Center of the Global Alzheimer's EpidemicJuly 18, 2011Biotech News - PR Newswire
Alzheimer's Association® TrialMatch™ Connects More Than 2,500 People with Alzheimer's Clinical Trials NationwideJuly 17, 2011Clinical Trials - PR Newswire
Two Studies Advance Global Standardization of Biomarkers for Alzheimer's DiseaseJuly 17, 2011Clinical Trials - PR Newswire
Alzheimer's Association Presents Lifetime Achievement Awards to Four ResearchersJuly 17, 2011Clinical Trials - PR Newswire
Falls May Indicate Earliest Stages of Alzheimer's and Need for Further EvaluationJuly 17, 2011Clinical Trials - PR Newswire
Avid CEO confident in Alzheimer's imaging agentJuly 16, 2011Health News - CNBC
Natural Chemical Found in Grapes May Protect Against Alzheimer's Disease, Mount Sinai School of Medicine Study July 15, 2011BioSpace - Featured Stories
Anavex to present at Alzheimer's Association International Conference on Alzheimer's DiseaseJuly 15, 2011Biotech News - PR Newswire
Key Alzheimer's Drug Development Stakeholders Join Forces To Establish Clinical Trial Safeguards And Accelerate DiscoveryJuly 12, 2011Medical Pharma - PR Newswire
Groups Convince FDA to Ease Alzheimer's Trial Rules; Move Could Improve Odds for Johnson & Johnson/Pfizer Inc. Drug July 12, 2011BioSpace - Breaking News
The Alzheimer's Drug Discovery Foundation and Charles River Collaborate to Create a New Cognitive Aging Research ProgramJuly 12, 2011Clinical Trials - PR Newswire
Pfizer, J&J's Alzheimer's drug might get boost from FDA trial rules July 12, 2011FierceBiotech
Groups convince FDA to ease Alzheimer's trial rulesJuly 12, 2011Health News - CNBC
Anavex Life Sciences Corp. rapidly advances ANAVEX 2-73 for Alzheimer's disease, Phase I clinical trial progressing well July 06, 2011BioSpace - Breaking News
Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a TrialJuly 06, 2011Biotech News - PR Newswire
Anavex rapidly advances ANAVEX 2-73 for Alzheimer's disease, Phase I clinical trial progressing wellJuly 06, 2011Biotech News - PR Newswire
Quintiles makes further investment to accelerate Prana's Alzheimer's drugJuly 02, 2011Biotechnology - Moreover
Mystery Ingredient in Coffee Boosts Protection Against Alzheimer's Disease, University of South Florida Study Finds June 29, 2011BioSpace
Alzheimer's center gets $6.9M grantJune 28, 2011Health News - BizJournals.com
UC Davis Alzheimer's center gets $6.9M grantJune 28, 2011Health News - BizJournals.com
Ablynx Receives EUR 5 Million in Milestone Payment From Alzheimer's Disease Collaboration With Boehringer IngelheimJune 27, 2011Marketwire - Pharma and Biotech
Experts warn U.S. to boost Alzheimer's fundingJune 23, 2011Health News - CNBC
Project Lifesaver International Proudly Supports Daniel Jang and his Ride for Alzheimer's Awareness; 49 States, 4 corners and the Arctic CircleJune 23, 2011Medical Pharma - PR Newswire
New test may predict Alzheimer's early: studyJune 22, 2011Health News - CNBC
Alzheimer's Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimer's DiseaseJune 22, 2011Pharma News - PharmiWeb
Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration Invite Scientists to Apply for FTD Biomarkers GrantsJune 15, 2011Medical Pharma - PR Newswire
Research and Markets: Advances in Alzheimer's Disease Drug Discovery - Analyze the Potential of Active and Passive Immunization StrategiesJune 15, 2011Pharma News - Business Wire
Reportlinker Adds Advances in Alzheimer's Disease Drug DiscoveryJune 13, 2011Medical Pharma - PR Newswire
Quintiles Invests in Kareus for Phase I Trials of Alzheimer and Type 2 Diabetes TreatmentsJune 13, 2011Inside Industry - Gen
Quintiles Invests in Kareus for Phase I Trials of Alzheimer and Type 2 Diabetes DrugsJune 13, 2011Inside Industry - Gen
Alzheimer Disease - The Evaluation and Management of DementiaJune 10, 2011Pharmaceutical - Moreover
Slow-moving Alzheimer's can buy people more timeJune 07, 2011New Scientist - Health
Mylan receives approval for generic Alzheimer's drugJune 07, 2011Health News - BizJournals.com
FDA approves Teva's Alzheimer's drugJune 03, 2011Pharmaceutical - Moreover
FDA Approves Teva Alzheimer's GenericJune 02, 2011Pharmaceutical - Moreover
Adeona Pharmaceuticals Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based Therapy June 02, 2011BioSpace - Breaking News
Adeona Announces Positive Alzheimer's Subgroup Analysis that Supports Additional Clinical Study of Proprietary Zinc-Based TherapyJune 02, 2011Biotech News - PR Newswire
FDA OKs generic Alzheimer's treatmentJune 02, 2011Health News - BizJournals.com
FDA gives marketing approval for Teva generic Alzheimer's drugJune 02, 2011Pharmaceutical - Moreover
Israel's Teva launches generic version of Alzheimer's drug Aricept after getting US approvalJune 01, 2011Pharmaceutical - Moreover
Teva gets US OK for generic Alzheimer's drugJune 01, 2011Health News - CNBC
Research and Markets: The 2011 10th International Conference on Alzheimer's and Parkinson's Diseases: Post-Conference Review and AnalysisMay 31, 2011Biotech News - Business Wire
Vermillion Announces Notice of Allowance for Alzheimer PatentMay 25, 2011Biotech News - PR Newswire
Research and Markets: Alzheimer's Disease Pipeline Review Q1 2011 - A Snapshot of the Global Therapeutic Scenario for Alzheimer's DiseaseMay 24, 2011Pharmaceutical - Moreover
Anavex Life Sciences Corp.'S ANAVEX 2-73 advances Phase I clinical trial for Alzheimer's disease May 23, 2011BioSpace - Breaking News
ANAVEX 2-73 advances Phase I clinical trial for Alzheimer's diseaseMay 23, 2011Biotech News - PR Newswire
Alzheimer's Risk Gene May Damage Brain Decades Before Symptoms Show, University of California, Los Angeles (UCLA) Study May 19, 2011BioSpace
Anavex comments on new Alzheimer's disease diagnostic guidelinesMay 17, 2011Biotech News - PR Newswire
Scientists find gene that warns of Alzheimer's 50 years before symptomsMay 17, 2011FierceBiotech Research
Panel Recommends Large-scale Study to Assess Alzheimer's RiskMay 12, 2011Burrill Report
Every 69 Seconds Someone Develops Alzheimer's DiseaseMay 11, 2011Medical Pharma - PR Newswire
Public Citizen: Lilly study excluded key data on Alzheimer's imaging agentMay 11, 2011FierceBiotech
Mount Sinai Hosts 9th Annual International Alzheimer's SymposiumMay 10, 2011Medical Pharma - PR Newswire
NYC Man with Alzheimer's Recovered Quickly, Safely by Queens PD with EmSeeQ® Locator DeviceMay 10, 2011Medical Pharma - PR Newswire
Alzheimer's Association Salutes Advocate and Mountaineer Now Climbing Everest as Part of The 7 Summits Climb for Alzheimer'sMay 10, 2011Pharma News - PR Newswire
The 26th Colloque Médecine et Recherche of the Fondation Ipsen in the Series Alzheimer Disease : “Protein Quality Control in Neurodegenerative Diseases”May 10, 2011Pharma News - Business Wire
Being 'Housebound' Linked to Alzheimer's in Elderly, Duke University Study Finds April 26, 2011BioSpace
Vaccine to halt Alzheimer's could be available within few yearsApril 26, 2011Biotechnology - Moreover
Alois Alzheimer Center picks Animal Instinct AdvertisingApril 25, 2011Health News - BizJournals.com
Researchers eager to see pivotal Alzheimer's data on bapineuzumabApril 25, 2011FierceBiotech
Wockhardt Gets Tentative FDA Approval For Generic Alzheimer Treatment April 25, 2011BioSpace
Wockhardt's Alzheimer's drug gets USFDA nodApril 25, 2011Pharmaceutical - Moreover
Wockhardt generic to treat Alzheimer's gets USFDA nodApril 25, 2011Pharmaceutical - Moreover
The Alzheimer's Association Receives Major Pledge From The TJX Companies, Inc.April 21, 2011Pharma News - PharmiWeb
ANAVEX: FIRST-IN-HUMAN DOSING COMMENCED IN ANAVEX 2-73 CLINICAL TRIAL FOR ALZHEIMER'S DISEASEApril 20, 2011Biotech News - PR Newswire
Alzheimer's Foundation to Hold National Memory Screening DayApril 19, 2011Marketwire - Pharma and Biotech
Alzheimer's redefined to help diagnosisApril 19, 2011CNN Top Stories
Osta Announces Promising Results on New Experimental Drug for Alzheimer's DiseaseApril 19, 2011Marketwire - Pharma and Biotech
Definition of Alzheimer's changing after 27 yearsApril 19, 2011Health News - BizJournals.com
New Criteria and Guidelines for the Diagnosis of Alzheimer's Disease Published for First Time in 27 YearsApril 19, 2011Medical Pharma - PR Newswire
StemCells Inc. to pursue Alzheimer's with UC Irvine professor Frank LaFerlaApril 18, 2011Health News - BizJournals.com
StemCells Inc. (STEM) Advances Alzheimer's Disease Program Through Collaboration With Leading ResearcherApril 18, 2011Biotechnology - Moreover
Research and Markets: Early Diagnosis of Alzheimer's Disease - Benefits, Challenges and Recent DevelopmentsApril 18, 2011Pharma News - PharmiWeb
Brain shrinks a decade before Alzheimer's appearsApril 13, 2011Health News - CNBC
Quanterix Discovers Link Between Heart Attack-Induced Hypoxia and Suspected Alzheimer's Disease PathwayApril 12, 2011Clinical Trials - PR Newswire
Research and Markets: Global Alzheimer Prevalence and Drugs DemandApril 12, 2011Pharma News - Business Wire
Study: Forest Laboratories, Inc.'s Drug Memantine Ineffective for Mild Alzheimer's April 12, 2011BioSpace
Alzheimer's mice at center of academic vs. property rightsApril 09, 2011FierceBiotech Research
Alzheimer's May Meet Insulin's Match, University at Buffalo Study April 05, 2011BioSpace
Researchers Link Herpes to Alzheimer's Disease; "Cold Sores" Connected to Cognitive Decline, University of New Mexico and Collaborators Find April 05, 2011BioSpace
Alzheimer's researchers have five new genes to ponderApril 04, 2011FierceBiotech Research
Revalesio Presents Multiple Sclerosis and Alzheimer's Disease Research at National Neurology ConferenceApril 04, 2011Biotechnology - Moreover
ExonHit Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer ResearchApril 04, 2011Biotech News - Business Wire
ExonHit annonce la publication des résultats de Phase IIa d’EHT 0202 dans Current Alzheimer ResearchApril 04, 2011Biotech News - Business Wire
Australian study of amyloid PET imaging for Alzheimer's gets fundingApril 04, 2011Biotechnology - Moreover
Five New Alzheimer's Genes Double Total as Doctors Unravel Disease Cause, Cardiff University Study April 04, 2011BioSpace
Scientists find five new Alzheimer's risk genesApril 03, 2011Health News - CNBC
Prana Biotechnology receives $0.7 million funding from Alzheimer Drug Discovery Foundation Deal In BriefApril 01, 2011Biotechnology - Moreover
PRANA Biotechnology (PRAN)'s PBT2 Phase 2 Trial Receives Funding From Alzheimer's Drug Discovery FoundationMarch 31, 2011Biotechnology - Moreover
Anavex Life Sciences Corp. Screening Healthy Volunteers For Phase I, First-In-Human Clinical Study In Alzheimer's Disease March 31, 2011BioSpace - Breaking News
Prana's PBT2 Phase II Trial Receives Funding From Alzheimer's Drug Discovery FoundationMarch 31, 2011Marketwire - Pharma and Biotech
ANAVEX SCREENING HEALTHY VOLUNTEERS FOR PHASE I, FIRST-IN-HUMAN CLINICAL STUDY IN ALZHEIMER'S DISEASEMarch 31, 2011Biotech News - PR Newswire
Alzheimer's Foundation of America Unveils Interactive 'Community of Care' Web Site to Educate and Connect Family CaregiversMarch 30, 2011Medical Pharma - PR Newswire
Dye slows ageing and Alzheimer's protein formationMarch 30, 2011New Scientist - Health
Asthma drug takes care of tricky Alzheimer's enzymeMarch 29, 2011FierceBiotech Research
Reportlinker Adds Biomarkers in Alzheimer's Disease, 2011March 29, 2011Medical Pharma - PR Newswire
Yuma Therapeutics Awarded a Research Grant by the Alzheimer's Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimer's DiseaseMarch 28, 2011Pharma News - PR Newswire
Biotech Stock on Watch; Prana Biotechnology Spikes on Alzheimer Drug NewsMarch 23, 2011Biotechnology - Moreover
Prana rockets on Alzheimer's studyMarch 22, 2011Biotechnology - Moreover
Research and Markets: Biomarkers in Alzheimer's Disease - 2011 ReportMarch 22, 2011Biotech News - Business Wire
Scientists deliver Alzheimer's drug directly into brainMarch 22, 2011Biotechnology - Moreover
Prana's PBT2 Repairs Alzheimer's Damaged BrainsMarch 21, 2011Biotechnology - Moreover
Alzheimer's brain drug could lead to moreMarch 21, 2011Biotechnology - Moreover
New Method Developed For Delivering Drugs To The Brain - Alzheimer's Society CommentMarch 21, 2011Biotechnology - Moreover
Drugs Breakthrough for Alzheimer's Patients, Oxford University Study March 21, 2011BioSpace - Featured Stories
Alzheimer's Drug Discovery Foundation Supports ADispell Technology with a Grant to Advance Novel Drug Candidates for Alzheimer's DiseaseMarch 21, 2011Biotech News - PR Newswire
New treatment for Alzheimer's diseaseMarch 21, 2011Biotechnology - Moreover
Alzheimer's Fuels a Healthcare Crisis March 18, 2011Burrill Report
FDA rejects Lilly, Avid Alzheimer's test dyeMarch 18, 2011FierceBiotech
Eli Lilly and Company Says FDA Denies Nod to Dye for Alzheimer's Test March 18, 2011BioSpace
FDA Stalls Approval of Lilly’s Alzheimer Disease Imaging AgentMarch 18, 2011Inside Industry - Gen
Animal data supports J&J's Alzheimer's vaccineMarch 17, 2011FierceVaccines
PRANA Biotechnology (PRAN)'s Lead Parkinson's Drug Presented at the 10th International Conference on Alzheimer's and Parkinson's DiseasesMarch 16, 2011Biotechnology - Moreover
Fisher Center for Alzheimer's Research Foundation Welcomes New Board Member, Dr. Manny AlvarezMarch 16, 2011Medical Pharma - PR Newswire
Alzheimer's and Diabetic Specialists Captivated by New Treatment Targeting Recently Discovered Type 3 DiabetesMarch 16, 2011Clinical Trials - PR Newswire
Prana's Lead Parkinson's Drug Presented at the 10th International Conference on Alzheimer's and Parkinson's Diseases Evidence of Novel Neuroprotective Mechanisms With Disease Modification PotentialMarch 15, 2011Biotechnology - Moreover
Prana's Lead Parkinson's Drug Presented at the 10th International Conference on Alzheimer's and Parkinson's DiseasesMarch 15, 2011Marketwire - Pharma and Biotech
Anavex Life Sciences Corp. Receives Approval to Commence Phase I Clinical Trial In Alzheimer's Disease March 15, 2011BioSpace - Breaking News
ExonHit Gets EC Clearance for Alzheimer Disease In Vitro DiagnosticMarch 15, 2011Inside Industry - Gen
ANAVEX RECEIVES APPROVAL TO COMMENCE PHASE I CLINICAL TRIAL IN ALZHEIMER'S DISEASEMarch 15, 2011Biotech News - PR Newswire
Making sense of the Alzheimer's drug pipeline (Page 2)March 15, 2011FierceBiotech Research
Making sense of the Alzheimer's drug pipelineMarch 15, 2011FierceBiotech Research
California prepares 10-year plan for Alzheimer's careMarch 14, 2011Health News - BizJournals.com
New animal data points to effectiveness of Alzheimer's vaccineMarch 14, 2011FierceBiotech
Johnson & Johnson's and Pfizer Inc.'s Bapineuzumab Might Tackle Alzheimer's Protein Early On March 11, 2011BioSpace
Allon Announces Presentation of Davunetide Data During 10th International Conference on Alzheimer's and Parkinson's DiseaseMarch 11, 2011Marketwire - Pharma and Biotech
AFFiRiS AG: Alzheimer's Vaccination Shows Promising ResultsMarch 11, 2011Biotech News - PR Newswire
Genetics and Location Add Up to Increased Alzheimer's Disease Risk, Johns Hopkins University Study March 10, 2011BioSpace
California Leaders Confront Alarming Rise in Alzheimer's CasesMarch 09, 2011Biotech News - PR Newswire
KineMed Extends Partnership With Bristol-Myers Squibb For Alzheimer's DiseaseMarch 09, 2011Biotechnology - Moreover
Study Points to Liver, Not Brain, as Origin of Alzheimer's PlaquesMarch 04, 2011Clinical Trials - PR Newswire
Brain Cells Grown in the Lab Will Help to Identify New Alzheimer's Drugs, Northwestern University Study March 04, 2011BioSpace
Lab-grown neurons might repair Alzheimer's brainsMarch 04, 2011New Scientist - Health
Research and Markets: Alzheimer's Disease Global Clinical Trials Review Q4 2010March 02, 2011Clinical Trials - Business Wire
NeuroPhage pockets $12.4M round for Alzheimer's workMarch 01, 2011FierceBiotech
Alzheimer's Disease May Be Passed Down From Ailing Mothers, University of Kansas Study Suggests March 01, 2011BioSpace
AFFiRiS Announces an Extension of its Existing Alzheimer's Disease Vaccine Development Collaboration With GlaxoSmithKline Triggering a Euro 3.5 Million Payment to AFFiRiSFebruary 28, 2011Biotech News - PR Newswire
Research and Markets: Alzheimer's Disease - Pipeline Review, Q4 2010February 28, 2011Pharma News - PharmiWeb
Alzheimer's ... Or Something Else? - Study February 25, 2011BioSpace
MetLife Foundation Announces Major Awards to Scientists for Research in Alzheimer's DiseaseFebruary 24, 2011Medical Pharma - PR Newswire
Alzheimer's Disease May Be Easily MisdiagnosedFebruary 23, 2011Clinical Trials - PR Newswire
David Cassidy, Alzheimer's Foundation hit 'Celebrity Apprentice'February 22, 2011Health News - BizJournals.com
David Cassidy to Compete in This Season's The Celebrity Apprentice for the Alzheimer's Research and Prevention FoundationFebruary 22, 2011Medical Pharma - PR Newswire
Alzheimer's Futurist to Bring Message to Menlo Park, Calif.February 22, 2011Pharma News - PharmiWeb
Adeona's Alzheimer's Disease Pivotal Clinical Study Results Abstract Accepted for Presentation at the American Academy of Neurology's 63rd Annual MeetingFebruary 08, 2011Pharma News - PR Newswire
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on Recent Alzheimer's Association ReportFebruary 07, 2011Pharmaceutical - Moreover
India's Sun Pharma gets FDA nod to sell generic Alzheimer's drug in US marketFebruary 03, 2011Pharmaceutical - Moreover
Sun gets US FDA nod to sell generic Alzheimer's disease drugFebruary 03, 2011Pharmaceutical - Moreover
First International Collaboration on the Genetics of Alzheimer's Disease Is LaunchedFebruary 01, 2011Clinical Trials - PR Newswire
Alzheimer's Drug Discovery Foundation Funds ALS Biopharma to Develop Small Molecules for Alzheimer's DiseaseJanuary 27, 2011Biotech News - PR Newswire
Investigators discover a new approach to Alzheimer's January 27, 2011FierceBiotech
Resverlogix ASSERT Trial Data Illustrates Potential for RVX-208 in Alzheimer's DiseaseJanuary 25, 2011Biotech News - PR Newswire
: Research and Markets: Assess the Importance of Baxter's 'Wild Card' Gammagard for Alzheimer's Disease, Currently In Phase IIIJanuary 24, 2011Pharmaceutical - Moreover
Research and Markets: Assess the Importance of Baxter's 'Wild Card' Gammagard for Alzheimer's Disease, Currently In Phase III Trials, In Driving Sales Growth Out To 2015January 21, 2011Pharma News - Business Wire
FDA panel sees promise in Alzheimer's imaging drugJanuary 20, 2011Health News - CNBC
The Alzheimer's Drug Discovery Foundation (ADDF) Organizes the 5th Drug Discovery for Neurodegeneration: An Intensive Course on Translating Research into DrugsJanuary 20, 2011Clinical Trials - PR Newswire
Cognition Therapeutics Inc. Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program January 20, 2011BioSpace
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences NewsJanuary 20, 2011Xconomy Life Sciences
Cognition Therapeutics Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment ProgramJanuary 20, 2011Biotech News - PR Newswire
Spotting Alzheimer's Disease...January 20, 2011Pharmaceutical - Moreover
Spotting Alzheimer's Disease EarlyJanuary 19, 2011Pharmaceutical - Moreover
Alzheimer's Foundation International Forms Alzheimer's Foundation of IsraelJanuary 18, 2011Medical Pharma - PR Newswire
Anavex comments on President Obama's signing of National Alzheimer's Project Act into lawJanuary 18, 2011Biotech News - PR Newswire
J&J teams up with Sanford-Burnham on Alzheimer's pactJanuary 18, 2011FierceBiotech
Adeona to Host Investor Day on Zinc Deficiency in Alzheimer's DiseaseJanuary 18, 2011Pharma News - PR Newswire
Takeda, Zinfandel link may revive ACTOS in Alzheimer's diseaseJanuary 17, 2011Pharmaceutical - Moreover
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's DiseaseJanuary 14, 2011Biotech News - PR Newswire
Opko Health, Inc. to Partner with Bristol-Myers Squibb Company on Blood Test for Alzheimer's Disease January 14, 2011BioSpace
Reportlinker Adds Epidemiology: Alzheimer's DiseaseJanuary 13, 2011Medical Pharma - PR Newswire
Takeda and Zinfandel to Develop Test to Identify Alzheimer's RiskJanuary 13, 2011Pharmaceutical - Moreover
Study in mice indicates disease's underlying causes, finds compounds that normalize Alzheimer's brainJanuary 13, 2011Pharmaceutical - Moreover
Brain swelling reported in Lilly Alzheimer's trialJanuary 12, 2011FierceBiotech
Eli Lilly and Company Says Brain Swelling Seen in Alzheimer's Study Patient January 12, 2011BioSpace
Study reveals underlying causes for degeneration of synapses in Alzheimer's DiseaseJanuary 12, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Zinfandel Pharmaceuticals Inc. Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; Zinfandel to Receive $9M Upfront, Payments of up to $January 11, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Zinfandel Pharmaceuticals Inc. Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; Zinfandel to Receive $9M Upfront, Payments of up to $78MJanuary 11, 2011Pharmaceutical - Moreover
The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's DiseaseJanuary 11, 2011Pharma News - PR Newswire
Takeda Pharmaceutical Co. Ltd. and Zinfandel Pharmaceuticals Inc. Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; to Receive $9M Upfront, Payments of up to $78M January 11, 2011BioSpace
Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in CJanuary 11, 2011Pharmaceutical - Moreover
Takeda Pharmaceutical Co. Ltd. and Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone January 11, 2011BioSpace - Breaking News
Takeda Pharmaceutical Co. Ltd. and Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone; to Receive $9M Upfront, Payments of up to $78M January 11, 2011BioSpace - Breaking News
Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone (PRN)January 10, 2011Pharmaceutical - Moreover
Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with PioglitazoneJanuary 10, 2011Biotech News - PR Newswire
Opko Health And Bristol-Myers Squibb Co. To Collaborate On Alzheimer's TestJanuary 10, 2011Pharmaceutical - Moreover
ORYZON Genomics Awarded a $300,000 Research Grant to Accelerate Development of Novel Therapeutics for Alzheimer's Disease January 10, 2011BioSpace - Breaking News
ORYZON Awarded a $300,000 Research Grant to Accelerate Development of Novel Therapeutics for Alzheimer's DiseaseJanuary 10, 2011Medical Pharma - PR Newswire
Alzheimer's Weekly names ANAVEX 2-73 the number one most promising trial drug in Alzheimer's disease and Anavex's Phase I clinical program as "Trial of the Year"January 06, 2011Biotech News - PR Newswire
Xiangxue Pharmaceutical Developing Alzheimer's TreatmentDecember 29, 2010Pharmaceutical - Moreover
Xiangxue Pharma Developing Alzheimer's TreatmentDecember 28, 2010Pharmaceutical - Moreover
Intellect Neurosciences, Inc. Obtains Pharmacokinetic Profile Report From Fourteen Day Safety Trial for the Company's Lead Alzheimer's Candidate, OX1December 27, 2010Pharmaceutical - Moreover
Elan Pharmaceuticals Pays Transition Therapeutics Inc. $9M in Amended Deal for Phase II Alzheimer Candidate; Eligible for $11 Million More December 27, 2010BioSpace - Breaking News
Transition changes pact for Alzheimer's drugDecember 27, 2010Health News - CNBC
Anavex Life Sciences Corp. Files Phase I Regulatory Submission for ANAVEX 2-73 in Alzheimer's Disease December 22, 2010BioSpace - Breaking News
Research and Markets: Pipeline and Commercial Insight: Alzheimer's Disease - Market cautiously awaits the first generation of disease-modifying therapiesDecember 22, 2010Pharma News - Business Wire
Anavex files Phase I regulatory submission for ANAVEX 2-73 in Alzheimer's diseaseDecember 21, 2010Biotech News - PR Newswire
Eli Lilly and Company Completes $300 Million Acquisition of Avid Radiopharmaceuticals, Inc. and Announces Alzheimer's Imaging Agent to Get FDA Review December 21, 2010BioSpace
Lilly Alzheimer's imaging agent to get FDA reviewDecember 21, 2010Health News - CNBC
Neuronetrix Begins Pivotal Multi-Center Clinical Trial of Alzheimer's Diagnostic DeviceDecember 16, 2010Marketwire - Pharma and Biotech
Plaques And Tangles May Be A Symptom, Not The Cause Of Alzheimer's Disease, Rutgers University Study December 16, 2010BioSpace
Good Cholesterol May Lower Risk of Alzheimer's Disease, Columbia University Study December 14, 2010BioSpace
Protein reversed memory loss in Alzheimer's miceDecember 13, 2010Health News - CNBC
Alzheimer's And Heart Attacks Share The Same Genes, University of Bologna Study December 13, 2010BioSpace
Alzheimer's Hearing Explores Role Of Early Diagnostic Tools In Drug TrialsDecember 13, 2010Pharmaceutical - Moreover
Medicine: Alzheimer's and heart attacks share the same genesDecember 09, 2010Inside Industry - Gen
Neurokine Announces Completion of New Phase II Clinical Trial Plan for Treatment of Alzheimer's Type Memory Loss in CABG PatientsDecember 09, 2010Marketwire - Pharma and Biotech
Alzheimer's Foundation of America Official to Testify Before Congress and Urge Policymakers to Act Now on Alzheimer's Disease CrisisDecember 09, 2010Medical Pharma - PR Newswire
Metabolism models may explain why Alzheimer's disease kills some neurone types firstDecember 08, 2010Biotechnology - Moreover
Development of models for Alzheimer disease in relation to brain energy metabolismDecember 08, 2010Biotechnology - Moreover
Metabolism models may explain why Alzheimer's disease kills some neuron types firstDecember 07, 2010Biotechnology - Moreover
Medivation Completes Enrollment in Phase 3 'CONCERT' Trial of Dimebon Added to Donepezil in Patients With Alzheimer's DiseaseDecember 07, 2010Pharma News - PR Newswire
GE Healthcare and Johnson & Johnson's Janssen Pharmaceutica N.V. Deal Pairs Two Alzheimer's Powerhouses December 03, 2010BioSpace
Insurance Leader Praises Obama for Promoting Enhanced Long-Term Care for Alzheimer's SufferersDecember 02, 2010Medical Pharma - PR Newswire
GE teams up with J&J on hunt for early Alzheimer's biomarkersDecember 02, 2010FierceBiotech
QR Pharma Receives FDA Clearance to Conduct Clinical Trials with Its Second Novel Alzheimer Compound, BisnorcymserineDecember 02, 2010FDA News - Business Wire
Janssen Pharmaceutica N.V., GE Healthcare Announce Collaboration to Develop Diagnostic Biosignatures for Pre-Symptomatic Identification of Alzheimer's DiseaseDecember 02, 2010Pharmaceutical - Moreover
GE Healthcare Announces Major Research Collaboration to Identify Diagnostic Biosignatures in Early Alzheimer's Disease DetectionDecember 01, 2010Biotech News - PR Newswire
Janssen Pharmaceutica N.V. Announces Collaboration to Develop Diagnostic Biosignatures for Pre-Symptomatic Identification of Alzheimer's DiseaseDecember 01, 2010Biotech News - PR Newswire
Sun given US approval to market Alzheimer's drugNovember 30, 2010Pharmaceutical - Moreover
Sun Pharma receives USFDA nod for generic Alzheimer's drugNovember 30, 2010Pharmaceutical - Moreover
Ranbaxy Launches Generic Version Of Aricept Alzheimer Drug In USNovember 30, 2010Health News - Fox Business
International Alzheimer's Researcher and Inventor to Speak at Quietmind FoundationNovember 29, 2010Marketwire - Pharma and Biotech
Ranbaxy gets nod for Alzheimer's drugNovember 29, 2010Pharmaceutical - Moreover
Gene therapy prevents memory problems in mice with Alzheimer's diseaseNovember 28, 2010Inside Industry - Gen
Research and Markets: Alzheimer's - Treatment, Symptoms and ManagementNovember 24, 2010Pharma News - Business Wire
OSEO Pledges €10.4M for Alzheimer Diagnostic, Theranostic, and Therapeutic R&DNovember 18, 2010Inside Industry - Gen
Hope on the Horizon for Alzheimer's Patients and CaregiversNovember 18, 2010Medical Pharma - PR Newswire
Banner Alzheimer's Institute Executive Director, Dr. Eric Reiman, Named a Rock Star of Science ™ in GQ's December 'Men of the Year' EditionNovember 17, 2010Clinical Trials - PR Newswire
UC Irvine team: Alzheimer's vax shows promiseNovember 17, 2010FierceVaccines
Chemicals in Cigarette Smoke, Auto Exhaust and French Fries Accelerate the Development of Alzheimer's DiseaseNovember 17, 2010Medical Pharma - PR Newswire
New 'Stand Together for AD' Campaign Provides Strength, Support and Important Resources for 11 Million Alzheimer's CaregiversNovember 17, 2010Medical Pharma - PR Newswire
Effects of Blood Pressure Drug on Alzheimer's Disease Shown in Mouse, National Institute on Aging Study November 16, 2010BioSpace - Featured Stories
Effects of Blood Pressure Drug on Alzheimer's Disease Shown in Mouse, National Institute on Aging Study November 16, 2010BioSpace - Featured Stories
'Magic number' 695 opens up new areas for Alzheimer's researchNovember 15, 2010Inside Industry - Gen
Research Shows Mercury is a Likely Cause for Alzheimer's DiseaseNovember 15, 2010Pharma News - Business Wire
Prana Biotechnology Limited Broadcast on Plans to Advance Alzheimer's Clinical ...November 12, 2010Biotechnology - Moreover
Prana Biotechnology Limited Broadcast on Plans to Advance Alzheimer's Clinical Trial for PBT2November 11, 2010Marketwire - Pharma and Biotech
VIDEO From Pfizer Available on thenewsmarket.com: Alzheimer's Disease Caregiver SurveyNovember 11, 2010Medical Pharma - PR Newswire
Oligomerix, Inc. Awarded Phase II NIH Grant to Discover Novel Drugs for Alzheimer's DiseaseNovember 11, 2010Biotech News - PR Newswire
Alzheimer's May Begin In Middle Age, Can Be Predicted - StudyNovember 10, 2010Health News - Fox Business
Prana Plans to Advance to Advance Alzheimer's Clinical TrialNovember 10, 2010Biotechnology - Moreover
Bilingualism Delays Onset of Alzheimer's Symptoms, Study Finds November 09, 2010BioSpace - Featured Stories
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent to Raise Awareness of Growing Prevalence and Burden of Alzheimer's DiseaseNovember 09, 2010Pharma News - PR Newswire
Prana (PRAN) Says Plans to Advance Alzheimer's Clinical TrialNovember 08, 2010Biotechnology - Moreover
Alzheimer's Foundation of America's National Commemorative Candle Lighting to Honor Individuals Affected by Alzheimer's DiseaseNovember 08, 2010Medical Pharma - PR Newswire
Prana Biotechnology Plans to Advance Alzheimer's Clinical TrialNovember 08, 2010Marketwire - Pharma and Biotech
Studies Reveal New Protein Target for Treating Alzheimer's DiseaseNovember 08, 2010Medical Pharma - PR Newswire
Study Published This Week in Alzheimer's & Dementia: The Journal of the Alzheimer's Association Shows that Algal DHA Improved Memory and Learning in Healthy Adults Age 55 and OlderNovember 04, 2010Pharma News - PR Newswire
Research and Markets: U.S. Alzheimer's Disease Medication Market - Demographics & New Disease Modifying Drugs Boost the U.S. Alzheimers Medication MarketNovember 04, 2010Pharma News - Business Wire
Alzheimer's Foundation of America to Introduce Free Memory Screenings in SpanishNovember 03, 2010Medical Pharma - PR Newswire
Big Pharma looking for cure for Alzheimer's DiseaseNovember 03, 2010Pharmaceutical - Moreover
Will One of These be the Cure for Alzheimer's DiseaseNovember 02, 2010Pharmaceutical - Moreover
Almost 100 Alzheimer's drugs in researchNovember 02, 2010Pharmaceutical - Moreover
Alzheimer's Medication May Affect both Sleep and DepressionOctober 28, 2010Pharma News - PharmiWeb
Intellect Neurosciences, Inc. Obtains OX1 Phase 1b Draft Report Showing the Company's Lead Alzheimer's Candidate Was Safe and Well-Tolerated at All Dose Levels Tested October 27, 2010BioSpace - Breaking News
Smokers Burnt by Alzheimer's Risk Later in Life, and Kuopio University Hospital Study October 26, 2010BioSpace
'Possible Key to Alzheimer Medication'October 26, 2010Biotech News - PR Newswire
Alzheimer's protein can move from blood to brainOctober 21, 2010New Scientist - Health
Alzheimer's protein may spread through infectionOctober 21, 2010New Scientist - Health
Vitamin B12 May Reduce Risk of Alzheimer's Disease, Karolinska Institute Study October 19, 2010BioSpace
GE Healthcare: DaTSCAN(TM) Recommended in Updated European Guidelines for Diagnosis of Alzheimer's Disease October 15, 2010BioSpace - Breaking News
Nicotine Could Play Role in Alzheimer's Disease Therapy, Neuroscientists Discover, University of Maryland and Johns Hopkins University Study October 14, 2010BioSpace
Alzheimer's Disease Caregivers Identify Memory Loss, Personal Safety and Confusion as Top Three Concerns Related to Progression of Their Loved One's DiseaseOctober 14, 2010Pharma News - PR Newswire
DaTSCAN™ (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimer's DiseaseOctober 14, 2010Pharma News - PR Newswire
Adeona Announces Five Scientific Publications on Role of Copper Toxicity and Zinc Deficiency in Alzheimer's Disease and Cognitive DeclineOctober 12, 2010Pharma News - PR Newswire
Tasly and ProteoTech to Co-Develop Alzheimer's DrugOctober 11, 2010Pharmaceutical - Moreover
Star Scientific Comments on Roskamp Institute's Plans to Conduct Human Alzheimer's Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.October 07, 2010Pharma News - PR Newswire
Roskamp Institute to Begin Human Alzheimer's Clinical Trials With a Natural Compound in TobaccoOctober 07, 2010Pharma News - PR Newswire
NICE opens up early Alzheimer's treatmentOctober 07, 2010FiercePharma
New Findings Pull Back Curtain on Relationship between Iron and Alzheimer's Disease, Massachusetts General Hospital Study October 07, 2010BioSpace
Adeona Pharmaceuticals Completes 100% Enrollment in its Pivotal Alzheimer's Disease and Mild Cognitive Impairment Clinical Study October 06, 2010BioSpace - Breaking News
Low Testosterone Linked to Alzheimer's Disease, Saint Louis University School of Medicine and Collaborators Study October 06, 2010BioSpace
Adeona Completes 100% Enrollment in its Pivotal Alzheimer's Disease and Mild Cognitive Impairment Clinical StudyOctober 06, 2010Clinical Trials - PR Newswire
Intellect Neurosciences, Inc. Obtains New Patent for Alzheimer Monoclonal Antibodies From the United States Patent and Trademark Office; Milestone Supports Company's Mission to Develop Innovative Disease Modifying Treatments for Alzheimer's DiseaseOctober 05, 2010Pharmaceutical - Moreover
USF and Saneron get $2.6 million to develop Alzheimer's treatment using umbilcal cord blood cellsOctober 05, 2010Inside Industry - Gen
USF and Saneron get $2.6 million to develop Alzheimer's treatment using umbilical cord blood cellsOctober 05, 2010Inside Industry - Gen
Accera, Inc. Appoints President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease October 05, 2010BioSpace
ProteoTech And Tasly Pharmaceuticals Announce Alzheimer's Disease Drug Development Agreement For Exebryl-1®October 05, 2010Pharmaceutical - Moreover
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's DiseaseOctober 05, 2010Pharma News - PR Newswire
Tasly, ProteoTech sign Alzheimer drug Exebryl-1 development agreementOctober 05, 2010Pharmaceutical - Moreover
Caring.com Launches First Customizable Alzheimer's Resource for Family CaregiversOctober 05, 2010Medical Pharma - PR Newswire
ProteoTech and Tasly Pharmaceutical Announce Alzheimer's Disease Drug Development Agreement for Exebryl-1(R)October 04, 2010Pharmaceutical - Moreover
Depression and Cognitive Disorders: at the Onset of Alzheimer's DiseaseOctober 04, 2010Pharma News - PR Newswire
Research and Markets: U.S. Alzheimer's Disease Medication Markets - An In-Depth Analysis of Factors Affecting the Growth of This MarketOctober 04, 2010Pharma News - Business Wire
ProteoTech and Tasly Pharmaceuticals Announce Alzheimer's Disease Drug Development Agreement for Exebryl-1(R)October 04, 2010Medical Pharma - PR Newswire
ProteoTech e Tasly Pharmaceuticals anunciam acordo de desenvolvimento de medicamento para doença de Alzheimer para Exebryl-1(R)October 04, 2010Medical Pharma - PR Newswire
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Comments on World Alzheimer's ReportOctober 01, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp. (CURX) CEO Patrick S. Smith Comments on World Alzheimer's ReportSeptember 30, 2010Pharmaceutical - Moreover
Alzheimer's may prevent brain cancersSeptember 28, 2010FierceBiotech Research
Alzheimer's Fights Brain CancerSeptember 27, 2010Clinical Trials - PR Newswire
Southridge Partners II Enters Into an Equity Purchase Agreement with Curaxis Pharmaceutical for Clinical Alzheimer's Disease TrialsSeptember 27, 2010Pharma News - PR Newswire
Results of Successful Trial for Alzheimer Patients Applying Novel, Non-Invasive Technology to Be Revealed at Geneva ConferenceSeptember 27, 2010Biotech News - Business Wire
New Gene Linked To Higher Alzheimer's Disease Risk, University of Miami Study September 24, 2010BioSpace - Featured Stories
DiaGenic ASA: Highly Ranked Journal Of Alzheimer's Disease To Publish Two DiaGenic ADtect(R) ArticlesSeptember 23, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp. (CURX) Enters Into an Equity Line Agreement With Southridge Partners, II for Clinical Alzheimer's Disease TrialsSeptember 23, 2010Pharmaceutical - Moreover
Teva suffers setback on Alzheimer's treatmentSeptember 21, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Comments on Recent Alzheimer's Disease...September 21, 2010Pharmaceutical - Moreover
Importante informe revela costo global masivo del Alzheimer: 1% del PIB mundial - y en aumentoSeptember 21, 2010Medical Pharma - PR Newswire
Relatório de referência revela o enorme custo global do Alzheimer: 1% do PIB mundial - e aumentandoSeptember 21, 2010Medical Pharma - PR Newswire
Neuro-Biotech's Solution for a Doctor near You: Early Detection for Alzheimer's and Chronic Fatigue Syndrome!September 20, 2010Biotech News - PR Newswire
Researchers Identify Genetic Marker of Aggressive Alzheimer's Disease, Washington University School of Medicine Study September 17, 2010BioSpace - Featured Stories
Alzheimer's Drug Boosts Perceptual Learning in Healthy Adults, University of California, Berkeley (CAL) Study September 17, 2010BioSpace - Featured Stories
Gene Predicts How Fast Alzheimer's Progresses, University of Washington Study September 17, 2010BioSpace - Featured Stories
Alzheimer's drug boosts perceptual learning in healthy adultsSeptember 16, 2010Inside Industry - Gen
ANAVEX 2-73: JOURNAL OF PSYCHOPHARMACOLOGY PUBLISHES ANTI-AMNESIC AND NEUROPROTECTIVE DATA AGAINST AMYLOID TOXICITY FOR FIRST OF A NEW CLASS IN ALZHEIMER'S DISEASESeptember 13, 2010Biotech News - PR Newswire
Power3 Medical Hits a Grand Slam at ICAD With Four Alzheimer's Poster PresentationsSeptember 10, 2010Marketwire - Pharma and Biotech
Roche Bets $635 Million on Parkinson's, Alzheimer's ProgramsSeptember 10, 2010Burrill Report
New Alzheimer's approach may sidestep early snagsSeptember 08, 2010Health News - CNBC
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's TreatmentSeptember 08, 2010Pharmaceutical - Moreover
Reportlinker Adds Alzheimer's Disease: Drug Treatment Strategies, 2010September 07, 2010Medical Pharma - PR Newswire
Reportlinker Adds Alzheimer Disease Therapy Area Pipeline ReportSeptember 07, 2010Pharma News - PR Newswire
Roche, Sign $637M Early-Stage Parkinson, Alzheimer Deal September 07, 2010BioSpace
ReMYND scores $637M Alzheimer's deal with Roche September 07, 2010FierceBiotech
Reportlinker Adds Alzheimer Disease - New Drugs, Markets and CompaniesSeptember 07, 2010Medical Pharma - PR Newswire
Roche. Signs $637M Early-Stage Parkinson, Alzheimer Deal September 07, 2010BioSpace
The Emergence of New Biologic Agents From Eli Lilly and Johnson & Johnson/Pfizer Will Drive the Alzheimer's Disease Drug Market to More Than Triple From $4.3 Billion in 2009 to $13.3 Billion in 2019September 07, 2010Pharma News - PR Newswire
Scientists Find Protein Behind Alzheimer's PlaquesSeptember 02, 2010Burrill Report
Addex Pharmaceuticals Drug-Candidate Effective in Alzheimer's Disease Model September 02, 2010BioSpace - Breaking News
Cell Publishes on the Critical Role of Metals in Alzheimer's DiseaseSeptember 02, 2010Marketwire - Pharma and Biotech
Cancer Drug Gleevec May Offer Clue to Alzheimer's Cure, Study Published in Nature September 02, 2010BioSpace - Featured Stories
Nobel Prize-winner finds new path for Alzheimer's drugSeptember 02, 2010FierceBiotech
Cancer Drug May Offer Clue to Alzheimer's Cure, Study Published in Nature September 02, 2010BioSpace
Addex drug-candidate effective in Alzheimer's disease modelSeptember 02, 2010Marketwire - Pharma and Biotech
Alzheimer's Therapeutics Reviewed by NeuroInvestmentSeptember 01, 2010Marketwire - Pharma and Biotech
Fisher Scientists Discover Protein that Fuels Alzheimer's Disease, Promising New Treatments ExpectedSeptember 01, 2010Clinical Trials - PR Newswire
Alzheimer's Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer TechnologyAugust 26, 2010Clinical Trials - PR Newswire
Alzheimer's trial setback spurs an argument on ethics August 26, 2010FierceBiotech
New Alzheimer's Study Seeks to Find Earliest Clues to Disease ProgressionAugust 24, 2010Marketwire - Pharma and Biotech
QualityStocks News - Curaxis Pharmaceutical Corp. (ASCH.OB) Issues Optimistic View and Update on Alzheimer Drug Candidate - 8/20/10August 23, 2010Pharmaceutical - Moreover
Curaxis Pharma updates clinical development plans for Memryte to treat Alzheimer's diseaseAugust 21, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp. (ASCH.OB) Issues Optimistic View and Update on Alzheimer Drug CandidateAugust 19, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's TreatmentAugust 19, 2010Pharmaceutical - Moreover
Curaxis Pharmaceutical Corp. CEO Announces Plans for Further Clinical Trials for Alzheimer's Treatment August 19, 2010BioSpace - Breaking News
False Starts by Others Don't Discourage Intellect Neurosciences' Search for Alzheimer's TreatmentAugust 19, 2010Marketwire - Pharma and Biotech
Eli Lilly Shelves Potential Alzheimer's Drug: Treatment Made Symptoms WorseAugust 19, 2010Pharmaceutical - Moreover
Lilly Stops Alzheimer's Drug TrialsAugust 18, 2010New York Times- Pharmaceuticals
Lilly Alzheimer Drug’s Failure Puts Theory in QuestionAugust 18, 2010New York Times- Pharmaceuticals
Alzheimer's Drug Discovery Foundation Funds Cognition Therapeutics Inc. to Advance Disease-Modifying Small Molecule Drug Candidates for Alzheimer's Disease August 18, 2010BioSpace - Breaking News
Alzheimer's Drug Discovery Foundation Funds Cognition Therapeutics to Advance Disease-Modifying Small Molecule Drug Candidates for Alzheimer's DiseaseAugust 18, 2010Medical Pharma - PR Newswire
Lilly's Alzheimer's disaster spells trouble for entire classAugust 18, 2010FierceBiotech
Alzheimer's Breakthrough Ride(SM) Kicks Into High Gear at Halfway PointAugust 18, 2010Medical Pharma - PR Newswire
Summary Box: Lilly halts Alzheimer's drugAugust 17, 2010Health News - CNBC
Lilly Halts Development of Potential Alzheimer's Drug SemagacestatAugust 17, 2010Health News - Fox Business
Eli Lilly and Company Halts Development Of Alzheimer's Drug August 17, 2010BioSpace
Lilly Ceases Development of Alzheimer's DrugAugust 17, 2010Contract Pharma
Lilly halts development of Alzheimer's drugAugust 17, 2010Health News - CNBC
Eli Lilly Stops Development Of An Alzheimer's DrugAugust 17, 2010Health News - Fox Business
Lilly halts Phase III Alzheimer's programAugust 17, 2010FierceBiotech
Eli Lilly Halts Development of Alzheimer's DrugAugust 17, 2010Health News - CNBC
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical TrialsAugust 17, 2010Pharma News - PR Newswire
Data-sharing helps researchers in Alzheimer's fightAugust 13, 2010FierceBiotech IT
Data-sharing breeds Alzheimer's progressAugust 13, 2010FierceBiotech
Merck commits up to $289M for new Alzheimer's collaborationAugust 11, 2010FierceBiotech
<b>Alectos Therapeutics</b> Announces Collaboration With Merck & Co., Inc. to Develop Drugs for Alzheimer's Disease; <b>Alectos Therapeutics</b> Could Receive $289 Million August 11, 2010BioSpace
Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's DiseaseAugust 11, 2010Marketwire - Pharma and Biotech
Elan, Transition push ahead with troubled Alzheimer's drugAugust 10, 2010FierceBiotech
Anavex appoints contract research organizations to initiate Phase I/IIa clinical programs, regulatory strategies in Alzheimer's diseaseAugust 10, 2010Biotech News - PR Newswire
Prana Biotechnology Is Cited in New Scientist Magazine Article Titled "Alzheimer's Unlocked: New Keys to a Cure"August 03, 2010Marketwire - Pharma and Biotech
Alzheimer's unlocked: New keys to a cureJuly 29, 2010New Scientist - Health
"Longevity gene" used to cure Alzheimer's in miceJuly 27, 2010FierceBiotech Research
'Longevity' gene cures Alzheimer's in miceJuly 27, 2010FierceBiotech
Eisai Inc. and Pfizer Inc. Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease July 26, 2010BioSpace
Gene Curtails Alzheimer's In Mice, Massachusetts Institute of Technology (MIT) Study July 23, 2010BioSpace
Briefing: New ways to diagnose Alzheimer's earlierJuly 19, 2010New Scientist - Health
Neuronetrix Showcases New Cognitive Testing Device at the Alzheimer's Association Annual MeetingJuly 19, 2010Marketwire - Pharma and Biotech
Prana's Research Was Presented at International Conference on Alzheimer's Disease on July 14July 19, 2010Marketwire - Pharma and Biotech
Reportlinker Adds Alzheimer's Disease Immunotherapy Pipeline: Vaccines, Therapeutic Antibodies and Emerging StrategiesJuly 19, 2010Medical Pharma - PR Newswire
U.S. study may be ideal test for Alzheimer's drugsJuly 15, 2010Health News - CNBC
<b>Noscira</b> Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at <b>International Conference on Alzheimer's Disease (ICAD)</b> July 15, 2010BioSpace - Breaking News
Intellect Neurosciences, Inc. Encouraged by Clinical Trial Data in Relation to Its Alzheimer's Immunotherapy Patents and Technology July 15, 2010BioSpace - Breaking News
Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimer's Disease at International Conference on Alzheimer's Disease (ICAD)July 15, 2010Biotech News - PR Newswire
Can Eisai's new Alzheimer's drug fill blockbuster shoes?July 15, 2010FierceBiotech
Insulin Nasal Spray May Help Treat Alzheimer's July 15, 2010BioSpace
Alzheimer's Gene Acts on Middle-Aged People, Two U.S. Studies Indicate, Duke University Study July 15, 2010BioSpace
'HOT TOPICS' From the Alzheimer's Association International Conference on Alzheimer's Disease 2010July 14, 2010Clinical Trials - PR Newswire
New Research Advances from the Alzheimer's Association International Conference on Alzheimer's Disease 2010July 14, 2010Clinical Trials - PR Newswire
EnVivo Pharmaceuticals Announces Significant Results from GSM Transgenic Mouse Model for Alzheimer's DiseaseJuly 14, 2010Biotech News - PR Newswire
Biomarkers promise to revolutionize Alzheimer's researchJuly 14, 2010FierceBiotech
Four Big Pharmas Bet Big on Intellect Neurosciences' Platform to Treat Alzheimer's DiseaseJuly 14, 2010Marketwire - Pharma and Biotech
Late-stage Alzheimer's drug targets two key culpritsJuly 14, 2010FierceBiotech
Eli Lilly and Company (LLY)'s Risky Bet On Late Stage Alzheimer Treatments Aims to Fill $July 14, 2010Biotechnology - Moreover
PhII Alzheimer's drug targets two key culpritsJuly 14, 2010FierceBiotech
Updated Alzheimer's guidelines add very early stageJuly 13, 2010Health News - CNBC
New Research Presented at Alzheimer's Association International Conference on Alzheimer's Disease Indicates Alzheimer's Disease May Lead to Increased Comorbid Conditions and Economic BurdenJuly 13, 2010Clinical Trials - PR Newswire
Alzheimer's Disease May Increase Risk of Anemia and SeizuresJuly 13, 2010Clinical Trials - PR Newswire
Exercise, Vitamin D Seem to Cut Alzheimer's Risk, Harvard Medical School Study July 13, 2010BioSpace - Featured Stories
Eli Lilly and Company's Risky Bet On Late Stage Alzheimer Treatments Aims to Fill $10 Billion Gap July 13, 2010BioSpace
Exercise, Vitamin D Seem to Cut Alzheimer's Risk: Researchers, Harvard Medical School Study July 13, 2010BioSpace
<b>Technical University</b> Study Finds Larger Head Size May Help Alzheimer's Patients July 13, 2010BioSpace
Eli Lilly bets big on late-stage Alzheimer's drugsJuly 13, 2010FierceBiotech
An Obesity Gene, Known as FTO, Also May Increase Risk of Alzheimer's Disease and DementiaJuly 13, 2010Clinical Trials - PR Newswire
Match service aims to speed Alzheimer's researchJuly 12, 2010Health News - CNBC
Alzheimer's advances show need for better drugsJuly 12, 2010Health News - CNBC
Alzheimer's Association Launches New 'Research Center' Website to Expand Public's Knowledge About Alzheimer ResearchJuly 12, 2010Medical Pharma - PR Newswire
Alzheimer's Association Launches TrialMatch(TM) -First-of-its-Kind Clinical Trial Matching Service in Alzheimer'sJuly 12, 2010Clinical Trials - PR Newswire
Four Researchers Given Lifetime Achievement Awards By the Alzheimer's AssociationJuly 11, 2010Clinical Trials - PR Newswire
Pfizer Inc. to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at International Conference on Alzheimer's Disease July 09, 2010BioSpace - Breaking News
Data on Bayer HealthCare's Florbetaben PET Tracer to Be Presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010July 09, 2010Pharma News - PR Newswire
Pfizer to Present More Than 40 Abstracts on Pre-Clinical, Clinical and Outcomes Research at Alzheimer's Association International Conference on Alzheimer's DiseaseJuly 08, 2010Pharma News - PR Newswire
Research and Markets: Alzheimer Disease - New Drugs, Markets and CompaniesJuly 08, 2010Pharma News - Business Wire
VIDEO from Synaptic Digital and APREC: Drinking Apple Juice Improves Mood in Alzheimer's PatientsJuly 07, 2010Clinical Trials - PR Newswire
Adeona Completes Equity Financing and Provides Alzheimer's Disease Clinical Study UpdateJuly 06, 2010Pharma News - PR Newswire
Neuronetrix Announces Clinical Trial Collaboration With Premier Research Institutes for a New Alzheimer's Disease Diagnostic TestJuly 02, 2010Marketwire - Pharma and Biotech
Watson starts selling generic Alzheimer's drugJuly 01, 2010Health News - CNBC
New PBT2 Data in 2010 Hot Topics Session at International Conference on Alzheimer's DiseaseJuly 01, 2010Marketwire - Pharma and Biotech
Taking Fundraising to New Heights - MediciGlobal's Global eMarketing Director Jumps from 10,000 feet for Alzheimer's ResearchJune 30, 2010Clinical Trials - PR Newswire
Quintiles agrees to fund Prana's drug trial for Alzheimer's diseaseJune 29, 2010Biotechnology - Moreover
Vermillion Announces Issuance of Patent for Alzheimer's Disease DiagnosisJune 29, 2010Biotech News - PR Newswire
Pakistan: Tomatoes can carry oral vaccine against Alzheimer's The lowly tomato can also act as a vehicle for an oral vaccine against Alzheimer's, according to scientists.HyunSoon Kim of Korea Research Institute of Bioscience and Biotechnology (KRIBB) andJune 28, 2010Biotechnology - Moreover
Forest, Merz receive US FDA nod for Namenda XR to treat moderate to severe dementia of Alzheimer's typeJune 24, 2010Pharmaceutical - Moreover
French Ipsen optimistic about its Alzheimer treatment drugJune 23, 2010Pharmaceutical - Moreover
Forest Laboratories, Inc. and Merz Pharmaceuticals, LLC Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type June 22, 2010BioSpace
Common Alzheimer's Medication Helps Skills Necessary for Safe Driving, Study Suggests June 22, 2010BioSpace
Blanchette Rockefeller Neurosciences Institute Names West Virginia Health Innovator as Director of the Alzheimer's Outreach and Registry ProgramJune 21, 2010Medical Pharma - PR Newswire
Comprehensive Review of the Role of Metals in Alzheimer's DiseaseJune 21, 2010Marketwire - Pharma and Biotech
Feared Side Effect of Alzheimer's Drugs Is Unlikely, Washington University School of Medicine New Model Suggests June 21, 2010BioSpace
[Review] Alzheimer's disease: clinical trials and drug developmentJune 18, 2010Pharmaceutical - Moreover
Alzheimer's clinical trial data made publicJune 16, 2010Pharmaceutical - Moreover
New Database of Alzheimer's Trials Available to Researchers, CliniciansJune 16, 2010Pharmaceutical - Moreover
Combined Industry Trial Data on Alzheimer's Disease Made Widely Available to ResearchersJune 15, 2010CenterWatch - Clinical Trials
Pharma companies share data to speed Alzheimer's researchJune 14, 2010Pharmaceutical - Moreover
: Big pharma agrees to share data to accelerate Alzheimer's researchJune 14, 2010Pharmaceutical - Moreover
Coalition to share Alzheimer's research dataJune 12, 2010Pharmaceutical - Moreover
Big pharmas to share Alzheimer's drug dataJune 11, 2010FierceBiotech IT
Alzheimer's database to be createdJune 11, 2010Pharmaceutical - Moreover
Public Release of Alzheimer's Clinical Trial Data By Pharmaceutical ResearchersJune 11, 2010Pharma News - PR Newswire
Big Pharma coalition will pool data on failed Alzheimer's drugsJune 11, 2010FierceBiotech
Allegiance Equity Corporation: PCT Patent Approved for CinGx(TM) to Treat and Prevent Diabetes, Alzheimer's and DementiasJune 08, 2010Marketwire - Pharma and Biotech
PCT Patent Approved for CinGx™ to Treat and Prevent Diabetes, Alzheimer's and DementiasJune 08, 2010Pharma News - PR Newswire
Adeona Announces Completion of 50% Enrollment in Part 2 of CopperProof-2 Study in Alzheimer's Disease and Mild Cognitive Impairment SubjectsJune 07, 2010Biotech News - PR Newswire
Grifols Initiates Clinical Investigation of New Treatment Protocol for Alzheimer's DiseaseJune 02, 2010Medical Pharma - PR Newswire
MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimer's Disease TrialsJune 02, 2010Biotech News - PR Newswire
Cognitive Decline in Alzheimer's and Autoimmune Diseases Linked to Common ProteinJune 02, 2010Medical Pharma - PR Newswire
CBDMT, The Market and Business Intelligence Company Reviews The Alzheimer's Disease MarketJune 01, 2010Pharmaceutical - Moreover
Down's eyes are clue to Alzheimer's diseaseMay 30, 2010New Scientist - Health
Banner Alzheimer's Institute Gets $6.5M From National Institutes of Health (NIH) for Alzheimer's Research; Will Create 130 Jobs May 28, 2010BioSpace - Breaking News
Alcohol Consumption May Protect Against Risk of Alzheimer's Disease, Particularly in Female Nonsmokers, Study Finds May 25, 2010BioSpace
Alzheimer's Drug Discovery Foundation Funds American Life Science Pharmaceuticals, Inc to Move Novel Therapeutic Towards ClinicMay 24, 2010Medical Pharma - PR Newswire
New Path for Novel Alzheimer's Therapies, Study May 24, 2010BioSpace
NANOBODY(R) LEAD CANDIDATE SELECTED BY BOEHRINGER INGELHEIM FOR DEVELOPMENT IN ALZHEIMER'S DISEASEMay 24, 2010Marketwire - Pharma and Biotech
Arizona Alzheimer's Conference Expects Record AttendanceMay 20, 2010Medical Pharma - PR Newswire
Alzheimer's costs to soar without effective drugsMay 19, 2010Health News - CNBC
Caffeine May Slow Alzheimer's Disease and Other Dementias, Restore Cognitive Function, Study in May 18, 2010BioSpace
Banner gets $6.5M for Alzheimer's researchMay 17, 2010Health News - BizJournals.com
Foundation Venture Capital Group Invests in Start-Up Company Developing Blood Test to Determine Risk and Diagnose Alzheimer's DiseaseMay 14, 2010Pharma News - PR Newswire
Knights give $15M for Alzheimer's research at Washington UniversityMay 12, 2010Health News - BizJournals.com
New Theory Of Alzheimer's Explains Drug Failures, Harvard Medical School And Brigham and Women's Hospital Study May 12, 2010BioSpace
BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimer's DiseaseMay 12, 2010Biotech News - PR Newswire
New Alzheimer Genes Fail for Risk Prediction, University Medical Center Study May 12, 2010BioSpace
EnVivo Pharmaceuticals, Inc. Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 May 11, 2010BioSpace - Breaking News
EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124May 11, 2010Biotech News - PR Newswire
Alzheimer's Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone TechnologyMay 06, 2010Pharma News - PR Newswire
Anavex reports animal study results as lead Alzheimer's compound approaches phase 1 clinical trialsMay 04, 2010Biotech News - PR Newswire
25th Colloque Médecine et Recherche of the Fondation Ipsen in the series Alzheimer Disease: “Two Faces of Evil: Cancer and Neurodegeneration”May 04, 2010Pharma News - Business Wire
Study Published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association Shows Algal DHA Improved Memory and Learning in Healthy Adults 55 and OlderMay 03, 2010Biotech News - PR Newswire
QR Pharma to Present on Alzheimer's Disease at the NeuroScienceNetworkMay 03, 2010Pharmaceutical - Moreover
IXICO Awarded Phase II Alzheimer's Disease StudyApril 30, 2010Pharmaceutical - Moreover
PRANA Biotechnology Provides Detailed Analysis of PBT2 Therapeutic Strategy for Alzheimer's Disease April 29, 2010BioSpace - Breaking News
National Institutes of Health (NIH) Panel: No Proven Way to Prevent Alzheimer's April 29, 2010BioSpace - Featured Stories
National Institutes of Health (NIH) Panel, No Proven Way to Prevent Alzheimer's April 29, 2010BioSpace
Prana Provides Detailed Analysis of PBT2 Therapeutic Strategy for Alzheimer's DiseaseApril 29, 2010Marketwire - Pharma and Biotech
AFFiRiS readies Alzheimer's vax for PhII studyApril 28, 2010FierceVaccines
New Alzheimer vaccine to be tested in EuropeApril 23, 2010Biotechnology - Moreover
AFFiRiS AG Alzheimer's Vaccine AD02 Already in Clinical Phase II April 23, 2010BioSpace - Breaking News
New Alzheimer vaccine to be tested in Europe (AFP) April 23, 2010Yahoo Biotech News
AFFiRiS AG: Alzheimer's Vaccine AD02 Already in Clinical Phase IIApril 23, 2010Biotech News - PR Newswire
Datamonitor Report: American Academy of Neurology 2010: New Treatments Address Unmet Needs In Alzheimer's And Epilepsy April 22, 2010BioSpace - Featured Stories
Prana Biotechnology to commence Phase II Alzheimer's trial - Zibb...April 22, 2010Biotechnology - Moreover
Samenvatting: Studie Octapharma over intraveneuze immunoglobuline (IVIG) bij ziekte van Alzheimer op ICAD 2010-congresApril 22, 2010Biotech News - Business Wire
Prana Biotechnology to commence Phase II Alzheimer's trialApril 22, 2010Biotechnology - Moreover
Promising New Drug Target for Alzheimer's Disease, University of Illinois Study April 21, 2010BioSpace
Prana To Begin Phase IIb Trial On Its Alzheimer's Disease Drug Candidate, PBT2 - Quick FactsApril 20, 2010Pharmaceutical - Moreover
Riassunto: Trial di Octapharma sull'immunoglobulina per via endovenosa (IVIG) nel trattamento dell'Alzheimer al congresso ICAD 2010April 20, 2010Biotech News - Business Wire
Estudo da Octapharma sobre imunoglobulina intravenosa (IVIG) em doença de Alzheimer no Congresso ICAD 2010April 20, 2010Biotech News - Business Wire
Presentación de ensayo de Octapharma sobre la inmunoglobulina endovenosa (IVIG) en la enfermedad de Alzheimer en el Congreso 2010 de la ICADApril 20, 2010Biotech News - Business Wire
New Article Affirms Prana's Alzheimer's TreatmentApril 19, 2010Biotechnology - Moreover
Octapharma Trial on Intravenous Immunoglobulin (IVIG) in Alzheimer's Disease at ICAD 2010 CongressApril 19, 2010Biotech News - Business Wire
New Analysis of Prana's Clinical Trial Is Published in the Journal of Alzheimer's DiseaseApril 19, 2010Marketwire - Pharma and Biotech
Brain-Imaging Study Supports the Relevance of a Common Genetic Risk Factor for Alzheimer's Disease in LatinosApril 14, 2010Clinical Trials - PR Newswire
Investigational Immune Intervention Slows Brain Shrinkage in Alzheimer's Patients, Weill Cornell Medical College Study April 14, 2010BioSpace
New Gene Associated With Increased Risk Of Alzheimer's Disease, University of Miami Study April 14, 2010BioSpace
Investigators Find Gene Linked to Risk of Late-Onset Alzheimer DiseaseApril 14, 2010GEN News Highlights
Yissum, Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's DiseApril 14, 2010Biotechnology - Moreover
Yissum Ltd., and Clal Biotechnology Industries Invest $9 Million in to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's Disease April 14, 2010BioSpace
Baxter International, Inc. Alzheimer's Treatment Shows Early Promise April 14, 2010BioSpace
Nicotine tied to Alzheimer's riskApril 14, 2010New Scientist - Health
Yissum, Pontifax, and Clal Biotechnology Industries Invest $9 Million in Avraham Pharmaceuticals to Pursue a Phase IIb Clinical Trial of Ladostigil, a Novel Drug for Treatment of Alzheimer's DiseaseApril 14, 2010Pharma News - Business Wire
Adeona Announces Positive Results of Part 1 of CopperProof-2 Study in Alzheimer's Disease and Mild Cognitive ImpairmentApril 14, 2010Marketwire - Pharma and Biotech
4/13/10 - Sun Pharma wins FDA tentative approval for generic Alzheimer's drugApril 13, 2010Pharmaceutical - Moreover
ViVre Medical Donates Thousands of LifeGuard30(TM) Medical Information Devices Through Victory Junction Camp, Alzheimer's Foundation of America and Project Lifesaver InternationalApril 13, 2010Medical Pharma - PR Newswire
Sun Pharma wins FDA tentative approval for generic Alzheimer's drugApril 13, 2010Pharmaceutical - Moreover
Diet Can Sharply Cut Alzheimer's Risk, Columbia University Study April 13, 2010BioSpace
AAN Issues Guideline on When People with Alzheimer's Disease Should Stop DrivingApril 12, 2010Clinical Trials - PR Newswire
Diet can sharply cut Alzheimer's risk: studyApril 12, 2010Science News - Reuters
Star Scientific Announces Collaboration with Roskamp Institute on Beta-amyloid Discovery and Alzheimer's DiseaseApril 09, 2010Pharma News - PharmiWeb
Local Researchers to Test First Transfer Agent to Improve Brain Function in Alzheimer's Disease PatientsApril 06, 2010Clinical Trials - PR Newswire
Researchers find "weak link" in Alzheimer's therapiesApril 05, 2010FierceBiotech Research
Weak Link In Alzheimer's Drug Candidates, University of California, San Diego (UCSD) Researchers Find Some Current Therapies Might Cause More Degeneration April 05, 2010BioSpace
TAKEDA, JANSSEN TO JOINTLY MARKET ALZHEIMER'S DRUG IN JAPANApril 05, 2010Pharmaceutical - Moreover
TAKEDA, JANSSEN TO JOINTLY MARKET ALZHEIMER'S DRUG IN JAPAN - Zib...April 05, 2010Pharmaceutical - Moreover
Approved Immunosuppressant Found to Be Effective in Mouse Model of Alzheimer DiseaseApril 02, 2010GEN News Highlights
Approved Immunosuppressant Found to Be Affective in Mouse Model of Alzheimer DiseaseApril 02, 2010GEN News Highlights
Drug That Extends Life Span Prevents Alzheimer's Deficits, University of Texas Health Science Center Study April 02, 2010BioSpace
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards ClinicMarch 31, 2010Clinical Trials - PR Newswire
ExonHit Therapeutics Inc. Presents New Data on its Alzheimer's Lead Candidate at the Symposium March 29, 2010BioSpace - Breaking News
Many Newly Diagnosed Alzheimer's Disease Patients Do Not Receive Alzheimer's Drugs As First-Line TherapyMarch 29, 2010Medical Pharma - PR Newswire
ExonHit présente de nouvelles données sur son candidat médicament phare dans la maladie d'Alzheimer au Symposium International de Genève/SpringfieldMarch 29, 2010Pharma News - Business Wire
New Test Takes Guesswork Out Of Diagnosing Early-Stage Alzheimer's Disease, Research March 26, 2010BioSpace
Research and Markets: Year 2010 to Witness Launch of Multiple Anti-Alzheimer Drugs in Japan - The CNS Market Outlook to 2014March 26, 2010Pharma News - Business Wire
Anesthesia Increases Risk of Developing Alzheimer's Disease in Patients With Genetic Predisposition, Study Suggests March 25, 2010BioSpace
Axonyx Off Hook For Alzheimer's Drug Securities SuitMarch 25, 2010Pharmaceutical - Moreover
Alzheimer Drug Test Result From Johnson & Johnson (JNJ) May Be Pushed Back to 20March 18, 2010Biotechnology - Moreover
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's DiseaseMarch 18, 2010Medical Pharma - PR Newswire
Alzheimer Drug Test Result From Johnson & Johnson May Be Pushed Back to 2012 March 18, 2010BioSpace
J&J rattles analysts with long delay for Alzheimer's programMarch 18, 2010FierceBiotech
Level of Gene Alters Risk of Alzheimer's Disease, Mayo Clinic Researchers Find March 17, 2010BioSpace
Early Identification of Alzheimer's Disease With PET ScanMarch 16, 2010Medical Pharma - PR Newswire
New Study Suggests Moderate Exercise May Increase Cognitive Function, Delay Alzheimer's DiseaseMarch 16, 2010Medical Pharma - PR Newswire
Hydra could be key in Alzheimer's studiesMarch 15, 2010FierceBiotech Research
Alzheimer Disease Therapy: Scientists at Uppsala University publish research in Alzheimer disease therapyMarch 13, 2010Biotechnology - Moreover
Anavex Life Sciences Corp. Comments on Failure of Pfizer Inc. and Medivation, Inc.'s Alzheimer's Investigational Drug Dimebon During Phase 3 Clinical Trials March 04, 2010BioSpace - Breaking News
State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease InternationalMarch 04, 2010Medical Pharma - PR Newswire
New Alzheimer's Prevention Efforts, and Non-Drug Treatments, Featured at 25th Conference of Alzheimer's Disease InternationalMarch 04, 2010Medical Pharma - PR Newswire
Summary Box: Alzheimer's drug fails in late testMarch 03, 2010Health News - CNBC
Current drugs for symptoms of Alzheimer's diseaseMarch 03, 2010Health News - CNBC
Anavex comments on failure of Pfizer and Medivation's Alzheimer's investigational drug Dimebon during Phase 3 clinical trialsMarch 03, 2010Biotech News - PR Newswire
Mount Sinai School of Medicine and Medisyn Technologies, Inc. Discover Novel Compounds for Alzheimer's Treatment March 03, 2010BioSpace - Breaking News
Medivation Shares Plunge As Alzheimer's Drug Fails TrialsMarch 03, 2010Health News - Fox Business
Medivation, Inc. to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's Disease March 03, 2010BioSpace - Breaking News
Pfizer and Medivation’s Alzheimer Drug Fails in First Phase III TrialMarch 03, 2010GEN News Highlights
Medivation, Inc., Pfizer Inc. Drug Dimebon Fails Phase 3 Alzheimer's Study March 03, 2010BioSpace - Breaking News
Pfizer, Medivation Alzheimer Drug Fails in Phase IIIMarch 03, 2010Contract Pharma
Pfizer Alzheimer's disease drug fails in studyMarch 03, 2010Health News - CNBC
Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Phase 3 Trial Results for Dimebon in Alzheimer's DiseaseMarch 03, 2010Clinical Trials - PR Newswire
Scientists Identify Sea Squirt as Model for Alzheimer Disease Research and Drug TestingMarch 02, 2010GEN News Highlights
Elan: Alzheimer's drug reduces brain plaqueMarch 01, 2010Health News - BizJournals.com
Medivation goes on Alzheimer's attack for $1B payoffMarch 01, 2010Health News - BizJournals.com
U.S. and German Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimer's DiseaseFebruary 25, 2010Medical Pharma - PR Newswire
Potential Early Diagnostic Biomarker for Alzheimer Disease in Healthy Adults IdentifiedFebruary 24, 2010GEN News Highlights
Results of Pilot Study Published in Journal of Alzheimer's Disease Reveal that Meditation Improves Cognition in those with Memory LossFebruary 24, 2010Clinical Trials - PR Newswire
US FDA Says Eisai Inc., Pfizer Inc. Alzheimer Ads Misleading February 22, 2010BioSpace
For the Treatment of Moderate to Severe Alzheimer's Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than EuropeFebruary 17, 2010Biotech News - PR Newswire
A Gene For Alzheimer's Makes You Smarter, Rush University Medical Center Study February 16, 2010BioSpace
25th International Conference of Alzheimer's Disease International March 10-13, 2010 - Thessaloniki, GreeceFebruary 12, 2010Pharma News - PharmiWeb
QR Pharma initiates Alzheimer's trialFebruary 11, 2010Pharmaceutical - Moreover
ExonHit Joins EU’s PharmaCog Alzheimer Disease ConsortiumFebruary 11, 2010GEN News Highlights
QR Pharma to starts trial on Alzheimer's drugFebruary 10, 2010Health News - BizJournals.com
Medivation, Inc. Alzheimer's Drug Dimebon Helps Huntington's, University of Rochester Study February 09, 2010BioSpace
Alzheimer's drug Dimebon helps Huntington's - studyFebruary 08, 2010Health News - CNBC
Marijuana Ineffective As An Alzheimer's Treatment: University of British Columbia-Study February 08, 2010BioSpace
Medivation, Inc.: Mystery Medicine for Alzheimer's May Yield Advance for Pfizer Inc. February 02, 2010BioSpace
Geron to Study Its hESC Product in Alzheimer Disease with University of CaliforniaJanuary 26, 2010GEN News Highlights
Geron to Study hESC Product in Alzheimer Disease with University of CaliforniaJanuary 26, 2010GEN News Highlights
First Alzheimer's Discussion at World Economic Forum Major Step ForwardJanuary 25, 2010Medical Pharma - PR Newswire
Lupin wins FDA tentative approval for Alzheimer's drugJanuary 24, 2010Pharmaceutical - Moreover
DiaGenic and Ferrer inCode sign distribution agreement for ADtect(R) early Alzheimer's TestJanuary 22, 2010Biotechnology - Moreover
Studies Find Link between Alzheimer Disease, Down Syndrome, and AtherosclerosisJanuary 18, 2010GEN News Highlights
Researchers Identify Proteins that Contribute to Memory Loss and Alzheimer DiseaseJanuary 15, 2010GEN News Highlights
New Compound Improves Cognitive Decline, Symptoms of Alzheimer's Disease in Rodents, Wake Forest University School of Medicine And Vanderbilt University Medical Center Study January 14, 2010BioSpace
The Alzheimer's Drug Discovery Foundation Accelerates Cures for Neurodegenerative DiseasesJanuary 13, 2010Medical Pharma - PR Newswire
For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 BillionJanuary 11, 2010Pharma News - PR Newswire
New Approach To Fighting Alzheimer's Shows Potential In Massachusetts Institute of Technology (MIT) Clinical Trial January 07, 2010BioSpace
Applied NeuroSolutions, Inc. Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and Company ; Will Receive Up-front Cash Payment of $750,000 and May Receive up to $25.5 Million in Milestone Payments December 22, 2009BioSpace
Applied NeuroSolutions Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and CompanyDecember 22, 2009Marketwire - Pharma and Biotech
Applied NeuroSolutions, Inc. Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and Company; Will Receive Up-front Cash Payment of $750,000 and May Receive up to $25.5 Million in Milestone Payments December 22, 2009BioSpace
FDA Approves First Generic Version of Pfizer and Eisai’s Alzheimer DrugDecember 16, 2009GEN News Highlights
Deaths force researchers to drop Alzheimer's drug dosesDecember 15, 2009FierceBiotech
Proteostasis Therapeutics, Inc. Scientific Founders Publish Paper in Establishing Role of the Proteostasis Network in Alzheimer's Disease December 15, 2009BioSpace - Breaking News
Elan Corporation PLC and Transition Therapeutics Inc. Drop Top Drug Doses After Nine Alzheimer's Patient Deaths December 15, 2009BioSpace
Butler Hospital Neurologist Lead Author of Ground Breaking Bio-Engineered Treatment Study for Alzheimer's DiseaseDecember 09, 2009Biotech News - PR Newswire
Gladstone Institute Scientists Identify Strategies To Protect New Brain Cells Against Alzheimer's Disease December 04, 2009BioSpace
Alzheimer's Research May Lead to Preventing the Debilitating DiseaseDecember 03, 2009Pharma News - PR Newswire
ExonHit Launches Alzheimer Diagnostic for Research UseDecember 03, 2009GEN News Highlights
Washington University in St. Louis Alzheimer's Study Leads to Better Drugs for Infections November 25, 2009BioSpace
TREVENTIS Scientific Founder Donald Weaver, MD, Named 2009 Recipient of Prix Galien Canada Award for Outstanding Achievement in Development of New Medicines for Alzheimer's DiseasePharma News - Business Wire
Research and Markets: Alzheimer's Disease Report - Drug Pipeline Analysis and Market Forecasts to 2015Pharma News - Business Wire



View all the latest news